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Anxiety and depressive disorders are among the most prevalent mental health 
problems among children and youth, although a considerable proportion of this group do not 
receive any help to relieve the problems. Anxiety and depression can lead to considerable 
problems with daily- functioning in the family, with friends, with leisure activities and with 
learning in school. There is a risk that the difficulties can worsen, become chronic, and that 
the individual develops additional problems with substance misuse and dropping out of 
school. The goals of this dissertation was to evaluate the rate of change for children and 
adolescents with anxiety and/or depression (hereafter referred to as emotional disorders) that 
had been treated within two Child and Adolescent Mental Health Services (CAMHS) in the 
North of Norway. Another goal was to investigate associations between different 
demographic and clinical characteristics of the child with rate of change during the CAMHS 
treatment.  
The empirical studies included in this dissertation are based on The Child and 
Adolescent Mental Health Services North (CAMHS North) Study. The CAMHS North study 
was a regional multicenter study including four CAMHS outpatient clinics in the northern part 
of Norway, and it was carried out in the time period between 2002 and 2008. The study was 
of naturalistic observational type where data from clinical instruments were collected as part 
of ordinary clinical practice. When this multicenter study was planned and designed, few 
other naturalistic and clinical studies about this health service existed in Norway. The study 
sample consisted of 84 children and youth with emotional disorders treated at two CAMHS in 
the North of Norway. The Strengths and Difficulties Questionnaire (SDQ), the Health of the 
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Nation Outcome Scale (HONOSCA) and the Children’s Global Assessment Scale (CGAS) 
were used as measures of change.  
Paper 1 is a literature review aimed at examining the extant research studies 
concerning pre-treatment child and adolescent characteristics as predictors and moderators of 
outcome in anxiety and depression psychotherapy treatment trials. In total, 44 published 
studies (32 anxiety studies and 12 depression studies) meeting the predefined methodological 
criteria were identified. The results showed that none of the pre-treatment demographic 
variables, such as age, gender and ethnic background, were found to consistently predict or 
moderate treatment outcome in both the anxiety and depression treatment trials, suggesting 
that the psychosocial treatments for anxiety and depression in children and youths are equally 
effective for girls and boys, young children and adolescents and across ethnic backgrounds. In 
the anxiety studies, no clinical factors (e.g. severity, comorbidity) were associated with 
differences in treatment change in the majority of studies. Among the depression treatment 
studies, higher levels of baseline symptomatic severity were associated with worse outcome in 
the majority of depression treatment studies that evaluated severity as predictor (3 out of 4 
studies). There was also some evidence that comorbid anxiety and depression can be negative 
prognostic factors of treatment response. The conclusion drawn from the literature review was 
that existing studies of pre-treatment patient variables as predictors and moderators of anxiety 
and depression treatment outcome provide little consistent knowledge concerning for whom 
and under what conditions treatments work.  
Paper 2 aimed at describing changes in symptomatic and functional impairment for 
children and youth with emotional disorders treated at two CAMHS in Norway. The results 
showed that children and youth with emotional disorders experience a statistically significant 
improvement per month during outpatient treatment according to nearly all the measures of 
change. For the clinician-rated scores, change rates during active assessment/treatment were 
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larger than during the waitlist period. Evaluating change from the perspective of clinical 
significance showed that only a small proportion of the subjects had statistically reliable and 
clinically significant change scores. Whether an actual change has occurred is uncertain for 
the majority of patients.  
Paper 3 aimed at examining demographic and clinical characteristics as potential 
predictors of change for children and youth with emotional disorders treated at two CAMHS 
in Norway. There was a difference between the two clinics in clinician rated functional 
impairment, where the CAMHS Silsand group was rated as more functionally impaired and 
with a steeper rate of change compared to the CAMHS Alta group of patients. The results 
showed that, according to clinician-rated total severity, youths with a diagnosis of depression 
had statistically higher symptom severity levels at baseline and significantly lower change 
rates as compared to youths with an anxiety disorder. No other variables were associated with 
differences in rate of change. The results point to a special need to improve clinical care for 
depressed children and adolescents. 
There is little knowledge about how the health service in Norwegian CAMHS works 
for different patient groups, and little is known about factors that may influence change during 
treatment.  The current studies add to this limited knowledge about children and adolescents 
with emotional disorders who have received health care in two Norwegian CAMHS.  
In sum, the results of these studies point to the importance of tracking change during 
CAMHS treatment and to study change through different approaches and from the viewpoint 
of different informants. Evaluating change both as statistically significant change at the group 
level, in comparison with waitlist rates of change and from the perspective of clinical 
significance at the individual level seems warranted. In addition, it is important to have 
sufficient data to reliably track change as rated both by children themselves, their 
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parents/other caregivers and clinicians. Focusing on prognostic factors for change during 
CAMHS service provision is also an important further venue. Many methodological 
limitations, which impact the interpretation of findings, are discussed. Important limitations 
affecting the external validity of the study concern selection bias, missing data, a small study 
sample, change measures, the lack of a control group, and clinician bias in reporting.  
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Sammendrag (abstract in Norwegian)  
Angstlidelser og depresjon er blant de mest vanlige psykiske lidelsene hos barn og 
ungdom samtidig som studier viser at et mindretall mottar hjelp for disse vanskene. 
Angstlidelser og depresjon kan medføre betydelige vansker med å fungere i hverdagen, i 
familieliv, med venner, i fritidsaktiviteter og på skolen. Det er en risiko for at vanskene kan 
forverres, bli kroniske, at personen utvikler tilleggsvansker som rusproblemer eller ikke 
fullfører skolegang. Målet med studiene i denne avhandlingen var å evaluere endringsrate hos 
barn og ungdom med angst og depresjon som har mottatt hjelp i Barne- og 
ungdomspsykiatrisk poliklinikk (BUP), samt å undersøke hvorvidt det er bestemte egenskaper 
hos barnet eller ungdommen som kan ha betydning for prognose i behandlingen.   
De empiriske studiene som utgjør grunnlaget for denne doktorgradsavhandlingen 
baserer seg på data fra BUP Nord studien. BUP Nord var en multisenterundersøkelse som ble 
gjennomført ved fire barne- og ungdomspsykiatriske poliklinikker (BUP) i Helse Nord i 
perioden 2002 – 2008.  Da studien ble utformet fantes det få naturalistiske og kliniske studier 
om denne helsetjenesten i Norge. Utvalget bestod av 84 barn og ungdom med angst og/eller 
depresjon som hadde mottatt et tilbud ved to BUP klinikker. Endringsmålene var Sterke og 
svake sider (SDQ-Nor), the Health of the Nation Outcome Scale (HONOSCA) og the 
Children’s Global Assessment Scale (CGAS). 
Artikkel 1 er en litteraturstudie, der en gjennomgår psykoterapeutiske 
behandlingsstudier som har fokusert på demografiske (eks. alder, kjønn) og kliniske 
egenskaper (eks. alvorlighetsgrad, komorbiditet: samtidig tilstedeværelse av flere psykiske 
lidelser) hos barn med potensiell betydning for endring under behandling. Artikkelen hadde til 
formål å skape en oversikt over forskningsfeltet i forkant av de empiriske studiene som er 
inkludert i denne avhandlingen. Totalt ble 44 publiserte studier inkludert (32 studier av 
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angstlidelser og 12 studier av depresjon). Resultat av litteraturgjennomgang viste at faktorer 
som alder, kjønn, og etnisk bakgrunn ikke var forbundet med forskjeller i behandlingsutfall 
for barn og ungdom med angst eller depresjon. Det var forskjell mellom studiene med fokus 
på primære angstlidelser, og studier av depresjonsbehandling. Ingen av de kliniske faktorene 
viste sammenheng med forskjell i behandlingsutfall for angstlidelser. Høyere alvorlighetsgrad 
ved oppstart viste sammenheng med lavere behandlingsrespons hos barn og ungdom med 
depresjon. Samtidig angstlidelse var forbundet med lavere behandlingsrespons i noen studier 
av depresjon. Konklusjonen av litteraturgjennomgangen var at en ut fra eksisterende studier 
har lite kunnskap om egenskaper ved barn og ungdom som kan ha betydning for endring 
under behandling, og en vet lite om for hvem og under hvilke betingelser behandling for angst 
og depresjon virker.  
I artikkel 2 ble endringer i symptomnivå og funksjonsnivå i løpet av et utrednings- og 
behandlingstilbud i BUP evaluert. Mål på endring av symptomer og funksjonsnivå fra barn og 
ungdom selv, foreldre og fagpersoner i BUP ble vurdert. Tre tilnærminger ble brukt for å 
evaluere endring, nemlig statistisk signifikant endring på gruppenivå, med ventelistekontroll, 
og ut fra klinisk signifikant endring på individnivå. Resultatene viste at barn og ungdom med 
angst og depresjon oppnår statistisk signifikant bedring per måned på gruppenivå i følge 
nesten alle endringsmål, i løpet av tidsperioden da de har hatt et tilbud ved BUP. I følge 
endringsmål fra fagpersoner i BUP så er endringene i perioden for utredning/behandling 
større enn tilsvarende endring under ventelisteperioden. Tilsvarende resultat for mål rapportert 
av ungdom og foreldre viser ikke forskjell mellom disse to tidsperiodene, men lav svarprosent 
gjør at disse resultatene må tolkes med varsomhet. Evaluering av endring ut fra klinisk 
signifikant endring viser at kun et fåtall individer kan klassifiseres som ”bedret”. For 
majoriteten er grad av endring usikker.  
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I artikkel 3 testes det hvorvidt ulike demografiske og kliniske egenskaper ved 
barnet/ungdommen har sammenheng med endringsrate i behandlingsforløpet. Resultatene 
viste en forskjell mellom klinikkene, der utvalget fra en av poliklinikkene var vurdert med 
signifikant lavere psykososial fungering ved inntak, og også en større grad av endring for 
fungering under behandlingsforløpet. Egenskaper som kjønn og alder ved inntak viste ikke 
sammenheng med grad av endring. Resultatene viste at barn og ungdom med depresjon hadde 
høyere verdier for klinikervurdert alvorlighetsgrad ved inntak, og de opplevde mindre grad av 
endring sammenlignet med barn og ungdom med angstlidelser.  
Det er begrenset kunnskap om hvordan helsetilbudet i BUP virker for ulike 
pasientgrupper, og egenskaper som kan virke inn på endring under behandling. Studiene 
innenfor denne avhandlingen er ett bidrag til å øke kunnskapen om barn og ungdom med 
angst og depresjon som mottar helsehjelp i BUP. Samlet indikerer funnene av disse studiene 
at det er viktig å måle endring under behandling i BUP og å evaluere endring ved hjelp av 
ulike statistiske og metodiske tilnærminger. Statistiske signifikant bedring på gruppenivå kan 
være en nyttig indikator på organisasjonsnivå, men sier ikke noe om helsetilbudets relative 
effekt. De fleste individer har høye skårer på henvisningstidspunktet, og mange vil oppleve en 
spontan bedring som ikke er relatert til selve helsetilbudet. Det er viktig å ta i bruke 
evalueringsmetoder som kan estimere helsetilbudets relative betydning for individenes 
endring. Ventelistekontroll er en måte å kunne estimere en slik effekt i de tilfeller hvor en 
mangler en kontrollgruppe. For den enkelte kliniker er det å evaluere endring ut fra klinisk 
signifikans på individnivå trolig en mer nyttig tilnærming. Denne avhandlingen viser også at 
det er behov for å undersøke faktorer som kan påvirke endring under behandling, og at 
kunnskapen man har om dette per i dag er lite entydig. Resultatene fra studiene i denne 
avhandlingen drøftes og sammenlignes med andre relevante studier. Metodiske begrensninger 
ved studiene i denne avhandlingen drøftes, og er viktige i forhold til tolkning av resultatene. 
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Introduction 
Background  
Back in 2006, when I started working as a clinical psychologist at the child and 
adolescent mental health outpatient services (CAMHS) in Tromsø. I became increasingly 
interested in working clinically with the group of children and adolescents with internalizing 
response patterns and with anxiety and depressive disorders (hereafter referred to as 
emotional disorders). At that time, the CAMHS Tromsø formed part of a large research 
program, The Incredible Years focusing on children with externalizing disorders, namely 
conduct disorders, oppositional defiant disorder, and hyperkinetic disorder. Little was known 
about the group of children with emotional disorders within the CAMHS system of care. 
Focusing on the group of children with emotional disorders was in line with both my clinical 
and research interests. 
In the present dissertation two major themes have been studied, namely change during 
CAMHS treatment and prognostic factors associated with rates of change. The target group is 
children and adolescents with emotional disorders. There is limited knowledge about rates of 
change during treatment as usual (TAU) in naturalistic settings. It is important to know 
whether children and adolescents accessing the service seem to be better off at follow up, and 
to be able to identify negative outcomes, or no change. Further, little is known about how the 
health service in Norwegian CAMHS works for different patient groups and about factors 
influencing change during treatment. The study of prognostic factors may contribute to a 
better understanding of what kind of treatment is effective for whom, and may facilitate the 
process of individualizing treatment interventions (Kraemer, Wilson, Fairburn, & Agras, 
2002; La Greca, Silverman, & Lochman, 2009). 
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The Child and Adolescent Mental Health Services North (CAMHS North) Study was a 
regional multicenter study including four CAMHS outpatient clinics in the northern part of 
Norway: CAMHS Alta, CAMHS Silsand, CAMHS Storslett and CAMHS Tromsø. The study 
was of a naturalistic observational type, where data from clinical instruments were collected 
as part of the ordinary clinical practice. The study was carried out in the time period between 
2002 and 2008. The primary aim of the multicenter study was to evaluate clinical procedures 
for assessment by implementing and evaluating structured instruments, to evaluate change 
during treatment, to investigate factors affecting waiting time, and to investigate user 
satisfaction. The outpatient clinics covered both urban and rural areas. The empirical studies 
of this dissertation only included participants from CAMHS Alta and Silsand, since these 
were the only clinics with follow-up data. CAMHS Alta collected data between 2002 and 
2005, while CAMHS Silsand collected data between 2004 and 2006.  
Child- and Adolescent psychiatry has been gradually developing from the 1960`s 
onwards, and is therefore a rather new service in Norway (Statens helsetilsyn, 2000). In 
Norwegian mental health services, 95 % of children and youth are treated in outpatient clinics 
(Brofoss, Larsen, Friis, & Norges forskningsråd, 2009). Child and adolescent psychiatry was 
targeted by the Norwegian government plan on improving the mental health care of the 
population during the decade between 1998 and 2008 (Brofoss et al., 2009). The goal of 
Norwegian health care authorities is that the outpatient CAMHS for children and adolescents 
shall be staffed to provide services for 5 % of the youth population (Tuseth, Sverdrup, Hjort, 
& Friestad, 2006). According to White Paper 25 (1996-97) and 39 (1998) it is an official 
requirement that the health care system must be based on research-based practice (Tuseth et 
al., 2006). Still, very few studies have been conducted regarding the quality of these services 
in Norway. Despite the focus on quality assurance and research-based practice, most CAMHS 
do not evaluate patient change systematically. To what extent the treatment provided within 
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Norwegian child psychiatry results in desired change for children and youth continues to be 
unknown.  
 
Emotional disorders: Anxiety and depression 
Emotional disorders are among the most prevalent mental health problems 
experienced by children, and are also among the largest groups within CAMHS. As results 
from The Bergen Child Study (BCS) indicate, Norwegian parents and teachers tend to under-
recognize this group of children (Heiervang, Goodman, & Goodman, 2008), and only 13 % of 
this group receive specialized mental health care. Among depressed adolescents, less than 20 
% had been in contact with specialized mental health services (Sund, Larsson, & Wichstrøm, 
2011).  
There are arguments, both pros and cons, as to whether one should study anxiety and 
depression together or separately (Wilkinson, 2009). The classification of symptoms of 
anxiety and depression into “emotional disturbance” in childhood psychopathology was firstly 
made by Hewitt and Jenkins in 1946 (reference in Wilkinson, 2009). The development of the 
diagnostic classification systems ICD (Helsetilsyn & World Health Organization, 1999) and 
DSM (American Psychiatric Association, 2013) has since that time contributed to a greater 
complexity and differentiation of childhood mental disorders, and the distinction between 
mood and anxiety disorders has been included in all subsequent versions. As stated in the 
introduction section of the DSM V (American Psychiatric Association, 2013) larger groupings 
of disorders have received more scientific support than the validation of individual diagnostic 
categories, and internalizing and externalizing factors are considered as a scientifically 
supported framework (Achenbach, Ivanova, Rescorla, Turner, & Althoff, 2016). 
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Anxiety and depression are regarded as distinct but related disorders (Cummings, 
Caporino, & Kendall, 2014), and there is an ongoing debate as to how the different anxiety 
and depressive disorders should be classified, categorized and grouped (e.g Beesdo, Pine, 
Lieb, & Wittchen, 2010; Mohr & Schneider, 2013). The principal emotions distinguish 
depressive disorder (depressed mood) and anxiety disorder (anxiety), while the secondary 
symptoms overlap considerably (e.g. difficulty with sleep, reduced concentration, rumination) 
(Wilkinson, 2009). In particular, there is considerable overlap between depressive disorder 
and generalized anxiety disorders (Kendler, 1996), and between social phobia and depressive 
disorders.  
Comorbidity refers to the co-occurrence of two or more distinct disorders in one 
individual. Anxiety and depressive disorders often co-occur (Melton, Croarkin, Strawn, & 
McClintock, 2016), and epidemiological studies show that it is common for children 
diagnosed with one anxiety disorders to display symptoms of other anxiety disorders and/or 
depressive symptoms (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003). Anxiety often 
occurs prior to the onset of depression (Strauss, Last, Hersen, & Kazdin, 1988). Rates of 
comorbidity between depression and anxiety disorders have ranged from 15.9 % to 61.9 % (in 
Beidel & Alfano, 2011, pp 33), but comorbidity is likely underestimated in children and 
adolescents (Melton et al., 2016). A meta-analysis of community epidemiological studies 
showed that 32 % of children/youth with major depression also had an anxiety disorder, and 
24 % of adolescents with an anxiety disorder had major depression (Angold, Costello, & 
Erkanli, 1999). An epidemiological study showed that during a 3-month period, 28 % of the 
youngsters with a depressive disorder also had an anxiety disorder (Costello et al., 2003). 
Generalized anxiety disorder and social phobia co-occur more frequently with depression 
compared to separation anxiety disorder and specific phobias (Verduin & Kendall, 2003). 
Comorbid anxiety and depression have a worse prognosis than either conditions alone, being 
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associated with more severe symptoms and greater functional impairment (Melton et al., 
2016). Neuroimaging research show that both distinct and common brain structures and 
neurocircuitry are involved in depression and anxiety, and some preliminary findings suggest 
that adolescent with anxiety with comorbid depression may have distinct patterns of structural 
and functional abnormalities compared to adolescents with either depression or anxiety 
disorders (Melton et al., 2016). 
 
Anxiety disorders 
Worldwide prevalence rates of anxiety disorders in children and adolescents show that 
these disorders are the most prevalent psychiatric conditions in childhood and adolescence 
(Beidel & Alfano, 2011), that rates increase with age (Beesdo, Knappe, & Pine, 2009; 
Esbjorn, Hoeyer, Dyrborg, Leth, & Kendall, 2010), and that more females than males have 
anxiety disorders. Epidemiological studies vary considerably in prevalence rates. Among pre-
adolescent children, epidemiologic studies have found prevalence rates ranging from 2.6 % to 
41.2 % (Cartwright-Hatton, McNicol, & Doubleday, 2006), and point prevalence rates 
ranging between 12 and 20 % in children and adolescents with different types of anxiety 
disorders (Costello, Egger, & Angold, 2005). The average age of onset differs depending on 
the specific anxiety diagnosis, but anxiety disorders can occur at any time during childhood 
and adolescence. Boys with anxiety disorders were referred at a younger age than girls to the 
CAMHS in Denmark (Esbjorn et al., 2010). The age groups of 7–12 year olds (boys) and 13–
19 years old (girls) were more frequently referred for treatment than boys and girls in other 
age groups.  
Anxiety disorders are sub-classified by the stimuli that trigger the anxiety. The most 
prevalent anxiety disorders among children and adolescents are separation anxiety disorder 
(SAD), generalized anxiety disorder (GAD), specific phobia (SP) and social phobia (SOC) 
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(Beesdo et al., 2009). Panic disorder and agoraphobia are rare in children, with an increasing 
prevalence during adolescence. In SAD, the child is overly anxious when faced with the 
potential separation from caregivers, from home, or by the concern of something happening to 
their caregivers. In SP, excessive fear is triggered when facing specific stimuli (e.g. certain 
animals, heights, small rooms). Generalized anxiety disorder (GAD) is characterized by 
excessive worry related to different topics and situations. Social phobia is characterized by a 
marked and consistent fear of negative evaluations in social and performance situations. 
Physiological symptoms of anxiety, such as increased heart rate, rapid breathing, trembling, 
muscle tension, are central diagnostic markers. Avoidance of the feared situation or stimuli is 
a behavioural diagnostic criterion in all anxiety diagnosis. The diagnosis of anxiety disorders 
lie on a continuum, where the level of distress and impairment caused by the anxiety 
(especially avoidance), is crucial for diagnostic evaluation. The aspect of normal development 
is important in the assessment of normal to maladaptive fear. Research suggests that anxiety 
disorders in childhood seem to function as a pacemaker for later psychiatric conditions 
(Wehry, Beesdo-Baum, Hennelly, Connolly, & Strawn, 2015) 
 
Depressive disorders 
The World Health Organization is ranking depression as the leading cause of disability 
worldwide, and as a major contributor to the overall burden of disease globally (WHO., 
2017). Depression affects around 3 % of children, and between 5-8 % of adolescents 
(Costello, Erkanli, & Angold, 2006). By the end of adolescence, however, around 28 % may 
have experienced a depressive episode (Lewinsohn, Rohde, & Seeley, 1998). Gender 
differences in depressive symptoms become apparent around the age of 13 with statistically 
significantly higher scores for girls than for boys (Twenge & Nolen-Hoeksema, 2002). The 
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prevalence of depression increases with age for both genders, but with the double rate for 
girls. Results from the Youth and Mental Health Study in Central Norway showed that the 
different depressive disorders all had long duration of episodes, and that the duration of 
episodes varied considerably (Sund et al., 2011). The mean episode duration of depression has 
been estimated to be between 4 to 9 months among clinically referred adolescents (Birmaher, 
Arbelaez, & Brent, 2002; Emslie, Mayes, Laptook, & Batt, 2003). In a Finnish study, 
approximately 50 % of depressive episodes lasted longer than the one year follow-up time 
(Karlsson et al., 2008). Around 2/3 of adolescents with a diagnosis of depression at age 15 
remain depressed at age 20, and the stability of depressive disorder was apparent in both 
genders (Agerup, Lydersen, Wallander, & Sund, 2014). 
Depressive disorders are syndromes of enduring emotional, biological and 
psychological symptoms with accompanying psychosocial impairment (Wilkinson, 2009). 
Major depression (DSM IV, American Psychiatric Association, 2000) and depressive episode 
(World Health Organization, 1992) are the most prevalent type of depressive disorders. The 
core symptoms of depression are depressed or irritable mood, and diminished interest or 
pleasure in almost all activities. Other common symptoms are changes in appetite/weight, 
changed sleep pattern, psychomotor agitation or retardation, reduced concentration or 
indecisiveness, reduced energy, increased fatigability, excessive feelings of worthlessness and 
guilt, recurrent thoughts of death or suicidal ideation. In the DSM IV, a diagnosis of major 
depression is characterized by at least five depressive symptoms that have been present most 
of the time for at least two weeks, and that are associated with a reduction of prior 
functioning. In the ICD-10, an assessment of the severity of the condition, whether it can be 
classified as mild, moderate or severe, is evaluated on the basis of numbers of symptoms and 
degree of functional impairment. Dysthymic disorder is characterized by a more chronic, yet 
less severe condition, with depressed mood most of the time accompanied by a minimum of 
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two other symptoms of depression. Minimum duration is one year. In DSM IV, depressive 
disorder not otherwise specified is characterized by a depressive condition that does not meet 
the full set of diagnostic criteria.   
The research field of depression in childhood and adolescence is relatively new, from 
the 1980’s onward. The study of depression and its treatments in children and adolescents has 
lagged behind advances in our understanding of other areas of psychopathology for this age 
group (Weisz, McCarty, & Valeri, 2006). 
 
The evaluation of change in mental health services 
A common definition of outcome in mental health is a measurable change in the 
mental health condition of the individual/group/population that can be attributed to an 
intervention or a service (Patterson, Matthey, & Baker, 2006). Several recommendations for 
the measurement and implementation of change data within CAMHS are presented in the 
literature (Wolpert et al., 2014a, 2014b). In short, the evaluation of change should be 
multidimensional (including changes in e.g. both symptoms and adaptive functioning), and 
multi-informant (both the clinician and the youth/caregiver perspective should be represented) 
(Wolpert, 2008). Measures included must have good psychometric properties, should be 
simple and quick to complete, be cost-effective and easy to interpret (Hall et al., 2014). Also, 
change should be evaluated and reported by taking into account both statistically- and 
clinically significant changes (Campbell, 2005), and to apply the most appropriate approach 
for the problem to be investigated, whether at the service level or at the individual level 
(Wolpert, Goerzig, et al., 2015). Different approaches to change evaluation may lead to 
different conclusions regarding the effectiveness of services, an observation reported in paper 
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2 of this dissertation, and from the Child Outcomes Research Consortium (CORC) data 
(Wolpert, Goerzig, et al., 2015). 
If we want to improve the mental health care of children, we need to know how it is 
currently working, what is functioning well and what is in need of improvement. Studies of 
the effectiveness of community-based usual care (UC) show that there is no convincing 
evidence of a strong clinical impact of outpatient specialty mental health care for children 
(Garland et al., 2013). Concerns about the limited effectiveness of usual care have influenced 
policy and research initiatives internationally with the goal of improving the quality of the 
services. In Great Britain, child and adolescent mental health services (CAMHS) are expected 
to evaluate change during service provision by systematically measuring outcome (Hall et al., 
2013). Through collaborative efforts such as the Child Outcomes Research Consortium 
(CORC), a non-profit learning collaboration formed in 2002 in Great Britain, routine outcome 
measurement is becoming more common in Great Britain, and is also spreading gradually to 
other European countries. Still, most CAMHS do not track patient change. In Norway, no 
such national initiative has been raised to evaluate the CAMHS service.  
What is currently known about the effectiveness of usual care within CAMHS for 
children and adolescents? Several studies have reported statistically significant improvement 
across diagnostic groups according to different change measures from intake to follow-up 
while in CAMHS care (Deighton et al., 2016; Lundh, Forsman, Serlachius, Lichtenstein, & 
Landen, 2013; Trask & Garland, 2012; Wolpert et al., 2012; Wolpert, Goerzig, et al., 2015), 
and effect sizes (ES) indicate positive, but modest effects (e.g Fugard et al., 2015; Wolpert, 
Cheng, & Deighton, 2015). Three studies reported results for anxiety disorder, depression, 
emotional disorders or internalizing problems separately. In one naturalistic observational 
study using archival data from CAMHS in Stockholm, Sweden, clinicians rated Children’s 
Global Assessment Scale (CGAS) indicated improvement in anxiety- and mood disorders 
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with similar change scores. Change scores for the mood disorder group was twice as large as 
for the group with ADHD. The authors state that the level of improvement reported for the 
mood disorder group correspond to efficacy trials in depression (March et al., 2004; Wagner, 
Jonas, Findling, Ventura, & Saikali, 2006), but no such comparisons with relevant treatment 
trials are made for the anxiety disorder group. A second study, including a large 
representative sample served within a large county mental health system in the USA, also 
suggest improvement in behavioural and emotional problems with effect sizes corresponding 
to the small to medium range (.39 to .69) after 6 months of treatment as usual (Trask & 
Garland, 2012). Although effect sizes were found to be unrelated to child diagnosis, the 
magnitude of change was smaller for internalizing problems when compared with 
externalizing problems. In a study from CAMHS in London (Day & Davis, 2006) reduction in 
total problems and burden scores corresponded to effect sizes in the medium to large range 
(0.5 to 1.0) that were maintained at 1-year follow up. While these findings suggest substantial 
improvement, the reduction of internalizing problems did not reach statistically significant 
results, and a significant number of children still had problems that qualified for clinical 
“caseness” after intervention. For all the above-mentioned studies, the lack of a control group 
is a challenge if one wishes to estimate the relative contribution of the service to change.  
Evaluating change from the perspective of clinical significant change and statistical 
reliable improvement indicates that the majority of children that receive community-based 
usual care (UC) do not experience clinical improvement (Garland et al., 2013; Warren, 
Nelson, Mondragon, Baldwin, & Burlingame, 2010). The reliable change index (RCI) is a 
statistics estimating if changes in psychometric measures may represent real change or occur 
by measurement error (Jacobson & Truax, 1991). It has been proposed as a means of 
meaningfully categorizing individuals as improved, unchanged or deteriorated. According to 
results on parent-rated Strengths and Difficulties Questionnaire (SDQ) from the CORC 
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database, 16.5 % were classified as ”improved” according to the reliable change index (RCI), 
while 2.3 % were classified as RCI ”worse” (Wolpert, Goerzig, et al., 2015). Manteuffel et al. 
(2008) used the reliable change index to examine patterns of change for 8484 youths in 45 
systems of care across 36 states of the USA. According to the results on parent rated data, an 
average of 36 % of youths improved, 50 % exhibited no reliable change and the remaining 14 
% exhibited poorer outcomes following treatment. Finally, also based on parent-rated data, 
Warren, Nelson and Burlingame (2009) reported that over 50 % did not achieve positive 
outcomes in therapy, and 21 % had significantly higher symptoms at the end of treatment, and 
an additional 30 % did not achieve a reliable change in symptom levels.  
Considering the lack of convincing evidence of a strong clinical impact of usual care 
within CAMHS the question raises of how usual care performs when compared to evidence 
based treatments? Weisz (2013) conducted a multi-level meta-analysis based on 52 studies 
comparing evidence based psychotherapies (EBI) with usual care. The results showed overall 
better outcomes for EBI´s, but the difference was modest and several usual care services 
outperformed EBI´s. Studies using exclusively diagnosed samples (d=0.09), and studies that 
focused on clinically referred youths (d=0.17) showed low and non-significant ES values, 
which seem to support the argument that EBIs have mostly been tested with subclinical 
youths, and therefore might not apply well to real-world clinical settings. The EBI – UC 
difference was also smaller in studies conducted outside North America, indicating that EBI is 
challenged by cultural differences. Outcome data from 30 child and adolescent mental health 
services in the UK showed both the evidence-based practice and non-evidence-based practice 
groups improved over time, with moderate effect sizes (Deighton et al., 2016). There were 
greater improvements associated with evidence-based practice (CBT) for children with 
emotional disorders, based on child self-reported symptoms, but not on parent reports. Thus, 
findings provide tentative support for evidence-based practice for the treatment of emotional 
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disorders in routine care settings - based on child self-report. In another meta-analysis 
(Spielmans, Gatlin, & McFall, 2010) the modest benefit of evidence-based treatments for 
youth was reduced when controlling for potential confounding factors (e.g. treatment dose, 
supervision, caseload). According to Ng and Weisz (2016), the relatively limited superiority 
of EBI compared to UC may be due to UC being highly individualized.  
What is the effect of psychological treatment for anxiety and depression in more controlled 
settings? Recent meta-analysis suggest that there has been a substantial decline in depression 
treatment effect sizes over time (Weersing, Jeffreys, Do, Schwartz, & Bolano, 2016), that 
effects are modest and that the effects of evidence based treatments for depression lag behind 
the effects for other youth disorders (Weisz et al., 2006). The decline in effect sizes may be 
partly due to actual progress within the field of depression treatment studies with more recent 
trials involving active control conditions. A meta-analysis on depression psychotherapy 
treatment trials published 10 years ago (Weisz et al., 2006), found an average effect size of 
0.34, falling in the small to medium range according to Cohen’s benchmark (Cohen, 1988), 
but there were considerable variations in effect sizes between studies. Also, beneficial 
changes showed no lasting effects, although few studies assessed effects at long-term follow-
up (Weersing et al., 2016; Weisz et al., 2006). Also, effects of CBT have been found to 
decline in the context of more severe, complex and clinically impaired depressed youths 
(Emslie, Kennard, & Mayes, 2011; March et al., 2004; Rohde, Waldron, Turner, Brody, & 
Jorgensen, 2014). In their review of predictors of depression treatment, Emslie et al. (2011) 
report 30 – 40 % experiencing remission of the depressive episode and recurrence rates within 
1 year as high as 50 %, among depressed children receiving evidence-based treatments Thus, 
the need for further developments of available depression treatments have been highlighted, 
and especially to increase the understanding of mechanisms of change in depression treatment 
(Weersing et al., 2016).  
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One recent review states that the evidence for psychological treatments of depressed 
children aged 12 years and below is inconclusive, probably due to the limited number of 
studies conducted in this age group (Forti-Buratti, Saikia, Wilkinson, & Ramchandani, 2016). 
A recently published review (Weersing et al., 2016) of 42 randomized controlled trials and of 
previously reviewed literature, points out that evidence for child depression treatment is 
weaker than for adolescent treatment. Cognitive behavioural therapy (CBT) was classified as 
possibly efficacious for children, while no child intervention could be classified as well 
established. For adolescents however, both CBT and interpersonal psychotherapy (IPT) could 
be classified as well-established interventions. The authors state that the dominance of CBT 
rests on the larger treatment outcome literature for CBT compared to other treatments (e.g 27 
RCT studies of CBT versus 6 for IPT), and not only on the strength of findings (Weersing et 
al., 2016). A recent meta-analysis concludes that CBT and interpersonal therapy (IPT) should 
be viewed as the best psychotherapies available at present, but several alternative 
psychotherapy approaches for depression are understudied (Zhou et al., 2015). In one review 
(Restifo & Bogels, 2009) the comparison of individual with family focused approaches to the 
treatment of adolescent depression yielded mixed results. Treating parent depression may be a 
promising approach for alleviating adolescent depression according to one review (Gunlicks 
& Weissman, 2008).  
 For the treatment of anxiety disorders in children and adolescents, the majority of 
approaches with strong support are CBT interventions and exposure based interventions 
(Higa-McMillan, Francis, Rith-Najarian, & Chorpita, 2016). Three meta-analytic reviews of 
evidence based treatments for anxiety disorders found clear beneficial effects of CBT when 
compared to passive controls (Ewing, Monsen, Thompson, Cartwright-Hatton, & Field, 2015; 
James, James, Cowdrey, Soler, & Choke, 2015; Reynolds, Wilson, Austin, & Hooper, 2012). 
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While the meta-analytic review by Reynolds (2012) found significant but small effect sizes 
favouring CBT when compared with active control conditions, the most recent Cochrane-
review found no evidence that CBT outperforms active controls such as non-CBT or 
treatment as usual (TAU) (James et al., 2015). Further, the meta-analytic review by Reynolds 
(2012) found that the overall effect sizes for generic CBT programs (targeting different 
anxiety disorders) were moderate, while the disorder specific treatments showed medium to 
large effect sizes. Also, anxiety treatments for adolescents showed large effects sizes, while 
treatments for children showed small to medium effect sizes. One meta-analysis found that 
individual treatment was more effective than group interventions (Reynolds et al., 2012), 
while other meta-analysis found no difference between individual and group intervention 
(Bennett et al., 2013; James et al., 2015). Two meta-analyses conclude that parental 
interventions were not associated with improved effects for anxious children and adolescents 
(James et al., 2015; Reynolds et al., 2012), and another meta-analytic review even found a 
small and non-significant effect size favouring child-only treatment (Thulin, Svirsky, 
Serlachius, Andersson, & Ost, 2014). A dose-response effect was also demonstrated 
suggesting that providing five or more sessions were associated with small effects, while 
providing nine or more sessions was associated with medium to large effect sizes (Reynolds 
et al., 2012).  
To sum up the results concerning outcomes in CAMHS usual care, results reported at 
the group level indicate positive results, although to a moderate extent. In most studies, 
surprisingly few individuals obtain clinical significant improvements. One venue further is to 
intensify efforts in understanding usual care practice, and to conduct rigorous research in 
naturalistic settings (Garland, Bickman, & Chorpita, 2010). One important step in 
individualizing treatments, and for improving the understanding of treatment effects and 
effectiveness, is to study prognostic factors that may impact change during treatment.  
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The study of predictors and moderators of change 
According to La Greca et al.’s (2009, pp 376) “Predictors of treatment outcome are 
variables that account for outcome irrespective of the treatment condition (main effect 
model)”. In paper 1, all studies were RCT studies, and predictors included were baseline 
characteristics of the child or adolescent that were associated with post-treatment diagnostic 
status or symptomatic level regardless of condition (in line with the approach presented in 
Kraemer et al., 2002). In paper 3, demographic and clinical characteristics of the individual 
measured at baseline were tested as potential predictors of rate of change per month at the 
group level, in line with the approach of Singer and Willet (2003). Clinically, predictors of 
treatment response may serve as prognostic variables and may highlight targets for further 
treatment development.  
Moderators of treatment outcome represent variables influencing the association 
between the intervention and the outcome (Baron & Kenny, 1986). A moderator variable 
affects the relationship between two variables, so that the nature of the impact of the predictor 
on the criterion varies according to the level or value of the moderator, i.e. an interactive 
effect. In paper 1 of the present dissertation, treatment moderators are baseline or pre-
randomization characteristics associated with differential responses to an intervention. This 
definition of moderator variable is applicable to RCT design where comparison with a control 
group is possible. Clinically, the identification of treatment moderators helps to specify for 
whom and under what circumstances the treatment works (Kraemer et al., 2002). For 
treatment development, moderators may help to identify limitations of treatments and areas of 
further development within the mechanisms of action of specific interventions. 
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As noted in paper 1, predictors and moderators of change have been primarily 
investigated in randomized controlled trials (RCT) of cognitive-behavioural therapy (CBT) in 
research clinics. When conducting an updated literature search for the preparation of this 
summary, seven naturalistic observation studies examining predictors and moderators of 
change were identified. The studies were all of patients with different diagnosis, and yielded 
mixed results. Gender was found to be unrelated to treatment outcome in most studies 
(Fuggle, 2015; Gordon, Antshel, & Lewandowski, 2012; Warren et al., 2009; Warren et al., 
2010), except one study which found that boys improved more on measures of internalizing 
behaviours than did girls (Trask & Garland, 2012). Age did not predict treatment outcome in 
most studies (Gordon et al., 2012; Trask & Garland, 2012; Warren et al., 2009; Warren et al., 
2010), although one study found that younger children have better outcomes than adolescents 
(Fuggle, 2015). Child’s diagnosis was not related to differential treatment outcome in two 
studies (Gordon et al., 2012; Trask & Garland, 2012), while one study found large differences 
in improvement depending on diagnostic group and the change score of the mood disorder 
group being twice as large as for the group with hyperkinetic disorder (Lundh et al., 2013).  
An updated literature review of studies examining predictors and moderators of 
outcome within the anxiety treatment literature showed that demographic factors, such as age 
and gender, do not predict or moderate differential treatment response rates or diagnostic 
recovery in most studies (Compton et al., 2014; Hudson, Keers, et al., 2015; Lundkvist-
Houndoumadi, Hougaard, & Thastum, 2014; Wergeland et al., 2016). Age was a moderator of 
treatment response in one study (Peris et al., 2015), and younger children showed steeper rates 
of improvement following exposure tasks compared to adolescents, indicating increased 
benefit of exposure. Several recent studies have found higher baseline anxiety severity 
(Compton et al., 2014; Lundkvist-Houndoumadi et al., 2014; Wergeland et al., 2016) to be 
associated with higher end-state anxiety levels, but not with the degree of improvement in 
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most studies. Higher pre-treatment anxiety was associated with higher symptom scores 
throughout treatment in a 16- to 20 week CBT program (Chu, Skriner, & Zandberg, 2013). 
Higher pre-treatment functional impairment was associated with less favourable outcomes 
post-treatment in one study (Wergeland et al., 2016). A diagnosis of social phobia has been 
found to predict less favourable outcomes of general CBT programs for anxiety in several 
studies (Compton et al., 2014; Hudson, Keers, et al., 2015; Hudson, Rapee, et al., 2015; 
Kerns, Read, Klugman, & Kendall, 2013; Wergeland et al., 2016). One study found that youth 
with social anxiety symptoms or diagnosis were significantly less improved also at 7.4-year 
follow-up (Kerns et al., 2013). The results indicate that children and adolescent with social 
anxiety may need more tailored interventions targeting explicit social skills training. One 
study found better outcomes for social phobia following a CBT treatment targeting cognitive 
characteristics of social phobia when compared to a general anxiety treatment program (the 
Coping Cat) (Ingul, Aune, & Nordahl, 2014). Findings regarding comorbid depression as a 
predictor of treatment response are inconclusive. Two studies found comorbid symptoms of 
depression to predict less favourable outcome of CBT treatment for anxiety (Hudson, Keers, 
et al., 2015; O'Neil & Kendall, 2012), while two other studies did not find this association 
(Kley, Heinrichs, Bender, & Tuschen-Caffier, 2012; Wergeland et al., 2016). Waters and 
colleagues (2015) found three characteristics of the child’s´ reaction pattern that was 
associated with more improvement following exposure training. Larger pre-treatment 
attention bias towards threat, greater emotional variability during exposure task, and larger 
habituation during the exposure training, were associated with more improvement from pre- 
to post-treatment.  
The study of predictors and moderators of outcome within the depression treatment 
literature to date show that demographic factors do not seem to have a substantial impact on 
the response to treatment (Emslie et al., 2011; Weersing et al., 2016). In a recent review of 
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psychosocial treatments of child and adolescent depression, the characteristics that were most 
consistently found to predict poor response across treatment and control conditions were 
higher levels of depression symptoms, poor global functioning, high levels of suicidality, 
comorbid anxiety, cognitive distortions, hopelessness and family conflict (Weersing et al., 
2016). In the Adolescent Depression Study, a naturalistic observational study, longer time to 
recovery was predicted by earlier age at onset of depression, poor psychosocial functioning, 
having a diagnosis of depression, and longer episode duration at study entry (Karlsson et al., 
2008).  
In paper 1, the review of predictors and moderators of treatment response in the 
Treatment for Adolescents with Depression (TADS), the Treatment of Resistant Depression 
in Adolescents (TORDIA) and the Adolescent Depression Antidepressants and Psychotherapy 
Trial (ADAPT) was described (Emslie et al., 2011). The TADS, the TORDIA and the 
ADAPT trials were all large-scale RCT-studies of medication, CBT or a combination of 
CBT/medication. Overall, demographic characteristics did not predict or moderate treatment 
outcome with a few exceptions. In the TADS, younger adolescents had better response to 
treatment than older adolescents. In the TORDIA, the older age group (18-19 years old) had 
better response to combination treatment. Gender had no overall effect on treatment response, 
but long-term outcome of the TADS study showed that girls were more likely to experience 
relapse over time. Across studies, greater improvement following acute treatment was 
associated with less severe depression at baseline, better functioning, shorter depression 
duration, fewer comorbid psychiatric disorders, less suicidal ideation and less hopelessness at 
baseline. In the TADS and the ADAPT, the absence of a comorbid anxiety disorder was 
associated with more improvement. In the TORDIA, anhedonia was the only dimension that 
predicted longer time to remission, and was also the only dimension to predict fewer 
depression-free days (McMakin et al., 2012). The authors state that anhedonia may represent 
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an important negative prognostic factor among treatment-resistant depressed adolescents. 
Since the CBT condition did not seem to be successful in alleviating symptoms of anhedonia, 
the authors raise the question of whether the current CBT treatments address anhedonia 
adequately. Further, in the TADS and the TORDIA, less family conflict and stress was also 
associated with more improvement. In another study, better baseline family functioning scores 
predicted a greater decrease in the adolescent depressions symptom scores, and also that 
families that had improved family functioning also showed significantly greater decreases in 
the youths’ CDI scores.  
To sum up the results on predictors and moderators of treatment effects, very few 
studies reported age and gender to be prognostic factors for anxiety and depression treatment 
outcome. Most investigations do not include large numbers of ethnic and racial minority 
youth, which limit the possibility to detect potential effects. Further, high pre-treatment 
severity of anxiety and depression predicts higher end-state levels of anxiety and depression, 
but is not necessarily predictive of the degree of improvement as seen in several studies. 
Another prevailing finding within both the anxiety and depression treatment literature to date 
is that very few of the studied variables show significant associations with change during 
treatment. Limitations of previous studies on predictors and moderators were described in 
paper 1 and will be further elaborated in the general discussion.  
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Aims of the thesis 
There is limited knowledge about rates of change during treatment as usual (TAU) in 
naturalistic settings and careful examination of treatment outcome and change processes in 
naturalistic settings of usual care is needed. There is also little knowledge about prognostic 
factors influencing change during treatment. The identification of predictors and moderators 
of change can help clarify which subgroups respond well, and which groups that respond less 
well to the services (La Greca et al., 2009).  
In the empirical studies of the present dissertation, the rate of change per month during 
CAMHS treatment is evaluated for children and adolescent with emotional disorders, and 
predictors of rates of change are assessed.  
The following main research questions were addressed in this dissertation:  
1. Based on the extant research literature review: To what extent have associations 
between child modalities and treatment outcome been confirmed?  
2. What are the changes in symptom severity, functional impairment and emotional 
problems as reported by adolescents and parents, and in symptom severity and 
functional impairment as reported by clinicians at the group level, as compared to 
waitlist control and from the perspective of clinical significant change?  
3. Are characteristics such as age, gender, baseline symptom severity or functional 
impairment, type of emotional disorder, comorbidity, prosocial characteristics and 
problem with peers associated with differences in rate of change over time?  
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Methods of paper 1 
Literature search: 
The aim of the literature review was to examine pre-treatment child and adolescent 
characteristics as predictors and moderators of outcome in anxiety and depression 
psychotherapy treatment trials. In order to identify relevant studies for inclusion in the review, 
I conducted literature searches in the ISI Web, PubMed, Medline (1985 through week 1 
March 2011), PsycINFO (1967 through week 1 March 2011). For the literature search in the 
databases ISI Web, Pub Med, Medline and PsycINFO lsearches, four key terms related to 
diagnosis (“anxiety disorder*” or ”depression” or ”emotional disorder*” or “internalizing 
disorder”) were paired with each of six key terms related to treatment (“predictor* treatment 
outcome” or “mechanism* of change treatment outcome” or  “moderator * treatment 
outcome” or “treatment outcome” or “treatment”), all paired with “Child* Youth* 
Adolescent*”. These search terms combined in the four databases yielded several thousand 
hits. For the PubMed and ISI Web databases I received weekly updates of relevant studies 
automatically. The literature search was conducted mainly during the spring of 2011 followed 
by some updated searches during the preparation and publication process in order to see 
whether new studies were published. Figure 1 displays a flowchart of the number of studies 
assessed for the present review. 1  







Figure 1. Flow chart of the search process 
 
 
The following criteria were used to select studies: The study must 1) conduct and present a 
statistical examination of child pre-treatment characteristics as possible predictors or 
moderators of treatment outcome, 2) be a treatment study with randomized controlled designs 
or controlled designs. Prevention studies were excluded, 3) be published in peer-reviewed 
journals from 1985 onwards, 4) target psychological treatments. Pharmacotherapy or 
combination studies were excluded, 5) be conducted in an outpatient setting, i.e. studies of 
inpatient treatment were excluded, 6) include a minimum of 50 subjects in post treatment 
analysis, 7) the study population must consist of children and/or adolescents 4 - 18 years of 

























with or without comorbid conditions. All diagnostic categories pertaining to Anxiety 
disorders according to DSM IV and ICD 10 criteria were included, excluding Post Traumatic 
Stress Disorder (PTSD) and Obsessive Compulsive Disorder (OCD). All diagnostic categories 
for unipolar depression according to DSM IV and ICD 10 criteria were included, excluding 
bipolar depressive disorder, 9) the study must report an outcome measure of anxiety and/or 
depression symptoms from multiple informants and/or diagnostic status of anxiety and/or 
depression, 10) the outcome measures must be conducted post-treatment. Studies reporting 
follow-up or maintenance outcomes only were excluded. In addition, only predictors and 
moderators that have been examined in more than one study were included in order to 
increase confidence in specific findings and to be able to compare the results of studies.  
 
Data analyses:  
A meta-analytic review would have been preferable for the summary of findings. Due to the 
variability in methodologies used to investigate predictors and moderators in the studies, both 
in terms of outcomes used, use of different informants, employing different statistical 
analyses and statistical corrections, it was not feasible to calculate pooled effect sizes for the 
degree of association between variables. The analytic strategy adopted for the review in paper 
1 was the box-score method, in which counts of statistically significant results were compared 
to non-significant results. 
 
Summary of studies:  
A total of 44 treatment trials were found. Thirty-two published papers based on 21 treatment 
studies for anxiety disorders and twelve published papers based on eight treatment studies for 
depression were selected for review. An overview of key characteristics of the studies is 
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presented in Table 1 (anxiety studies) and Table 2 (depression studies) in paper 1. All anxiety 
treatment studies represent comparisons of different protocols and formats of cognitive 
behaviour therapy (CBT) with other active treatments, or with a waitlist control condition. 
Only five anxiety studies were conducted in community mental health clinics, while the rest 
were carried out in university outpatient clinics. Among the publications on depression ten 
compared different protocols and formats of CBT with other active treatments or waitlist 
controls, and three publications investigated the effectiveness of Interpersonal Therapy (IPT-
A) compared to treatment as usual. Four of the studies were conducted in university outpatient 
clinics, one was conducted in community mental health clinics, and two studies had a mixed 
procedure with some patients treated in community outpatient clinics and some in university- 
based clinics. 
 
Methods of papers 2 and 3 
Sampling and participants 
The Child and Adolescent Mental Health Services North (CAMHS North) Study was 
described in the introduction. All individuals aged 5 to 18 years referred to the Alta Child and 
Adolescent Mental Health Outpatient Service at the Finnmark Hospital Trust (CAMHS Alta) 
and to the Silsand Child and Adolescent Mental Health Outpatient Service at the University 
Hospital of Northern Norway (CAMHS Silsand) were eligible for inclusion to the CAMHS 
North study. Alta is a town and administration center for the municipal of Alta, situated in the 
Western part of the county of Finnmark. Alta is also the largest town in Finnmark, and an 
important administrative, commercial and educational intersection for this northern most 
county in Norway. In 2002, when the study was initiated, the number of inhabitants in Alta 
was 17159. Silsand is a village close to the town of Finnsnes, which is situated in the 
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municipal of Lenvik in the central part of the county of Troms. Finnsnes is an administrative 
and commercial center for the region of central Troms, and in 2004 when the study was 
initiated at CAMHS Silsand the number of inhabitants in the region was 11080. Both centres 
cover semirural and rural areas.   
Among the 320 clients eligible for this part of the multi-centres study, only 276 
patients had data for the relevant change measures on one or more measurement occasions. A 
total of 284 patients were registered in the CAMHS Alta and CAMHS Silsand database. Eight 
patients were excluded in the first step due to the lack of demographic and clinical 
information. Among the eight patients, the only data available was results for the Wechsler 
Intelligence scale (WISC III) (n = 3), for the WISC III and some anamnestic information (n = 
2) and some anamnestic information (n = 3). Thus, a total of 276 individuals (CAMHS Alta N 
= 153, CAMHS Silsand N = 123) were included. In the next step, among the 276 patients with 
demographic and clinical information, three patients (1 boy, and two girls) were not included 
in the data analysis due to missing data for the targeted outcome measures. Thus, 273 patients 
had ratings registered for one or several of the outcome measures, for one or more 
measurement occasions.  
In the studies of the present dissertation, the target group was a subsample of 84 
patients with emotional disorders treated at two CAMHS in the north of Norway, CAMHS 
Alta (n = 56) and CAMHS Silsand (n = 28). Data from the self- and parent reported Strengths 
and Difficulties Questionnaire SDQ were not available for the entire sample. In Table 1 
(paper 2 and paper 3), characteristics of the study sample with available data for the different 
change measures are presented. Characteristics of the CAMHS Alta, the CAMHS Silsand 
sample, and the multicentre sample are presented in Table A1 (supplemental material of paper 
3). The sample consists of 56 girls (66.7 %) and 28 boys (33.3 %). The mean age of the 
sample was 12.49 years at intake and the girls (M = 13.21, SD = 2.65) were significantly older 
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(t (82) = - 3.24, p < .01) than the boys (M = 11.04, SD = 3.38). Twenty-seven patients (32.2 
%) were assessed as depressed (4 boys and 23 girls), 38 patients (45.2 %) as having one or 
more anxiety disorders (18 boys and 20 girls), and 19 patients (22.6 %) were assessed as 
having both depressive and anxiety problems (6 boys and 13 girls).  
 
Sample characteristics and representativeness 
Concerning age distribution, mean age for the group of children with depression was 
14.6 years at intake (88.9 % was in the age group 13-18 years). For the group with one or 
several anxiety disorders the mean age was 10.9 (57.8 % was in the group 6-12 years). For the 
group with both anxiety and depressive disorder the mean age was 12.6 (and age groups 6-12 
and 13-18 were equally represented). Gender and age distribution in our sample is consistent 
with other studies of anxiety disorders (Kendall et al., 2010), and of depressive disorder 
(March et al., 2005). Also, the age and gender distribution for depression correspond with a 
recent longitudinal epidemiological study of depression in Central Norway (Larsson, Ingul, 
Jozefiak, Leikanger, & Sund, 2016). Gender and age distribution of our total sample for 
children and adolescents with anxiety and depressive disorders is consistent with Norwegian 
National statistics of CAMHS from the time period of the CAMHS North study (Lidal, 2007) 
and recent Norwegian national statistics for CAMHS (Krogh, 2016) and to statistics of the 
Child Outcomes research Consortium (CORC) (Fugard et al., 2015).  
Children and adolescent with emotional disorders constituted 30.4 % of the total 
sample. This is similar to numbers reported from recent Norwegian National statistics of 
CAMHS (Krogh, 2016), as well as with statistics from the CORC (M. Wolpert et al., 2012).  
Parents provided information about their ethnicity, family arrangements (living with 
one or both biological parents, or other caregivers), parental judicial responsibility (both 
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parents or one parent alone) and mother tongue. The great majority of families were 
Norwegian, the largest proportion of children with emotional disorders were living with one 
of their parents, and the great majority defined Norwegian as their mother tongue.    
A follow-up (T2) assessment was not completed by the clinicians for 32.1 % (n = 27) 
of the sample for the HONOSCA and 38.1 % (n = 32) for the CGAS. The reason for non-
completion is unknown. The group of patients without follow-up data was not different from 
the rest of the sample as regards gender composition, mean age, age grouping and type of 
emotional disorder (depression, anxiety or mixed). Test statistics for comparison of the groups 
are presented in Table A2 and A3 (supplemental material of paper 3, attached in Appendix). 
 




Children and adolescents between the ages of 5 and 18 referred to the clinics between 2002 
and 2005 were asked to participate through both written and oral information. Before 
inclusion to the study, a written consent was obtained (see more detailed description in 
“Ethical considerations”). The only exclusion criteria were referral acute (e.g. concerning 

















not affect type of service offered. Non-participants were assessed and treated according to the 
same procedures as study participants. On three occasions, measures by means of 
questionnaires were repeated. The SDQ (self-, mother- and father- reported), the clinician 
rated HONOSCA and the CGAS were administered at intake (T0), during 
assessment/treatment (T1) and approximately six months after T1 (T2) or at termination. 
 
The procedure of the CAMHS North study is presented in figure 1. Standardization of the 
assessment procedures (T1) was one goal for the implementation of the CAMHS North Study. 
Also, other goals were to improve the efficiency of the assessment phase, and to complete the 
assessment before entering into treatment. Patients (both study participants and non-
participants) were assessed through the same assessment means. The T0 was an admission 
meeting with the child/adolescent and parents/caregiver. The SDQ, HONOSCA and the 
CGAS were completed after the meeting. Informed consent was obtained. In the assessment 
phase (T1), the Kiddie-SADS PL was used to aid diagnostic evaluation (Ambrosini, 2000; 
Kaufman et al., 1997) and was conducted separately with the parents and children > 11 years 
of age. An anamnestic interview was conducted with the parents. The SDQ, HONOSCA and 
the CGAS were repeated during the assessment phase. Further assessment of mental health, 
development and cognitive functioning was conducted on indication. In the clinics, the 
diagnostic evaluation following assessment was consensus based, and a specialist in clinical 
psychology or psychiatry approved the evaluations. Next, the clinicians met with the 
child/adolescent and caregivers to give feedback concerning the evaluation, the diagnostic 
assessment, and to agree upon further treatment plans. It was also accustomed to arrange 




Treatment practice was not changed because of the observational study, and the 
treatment given can be classified as “treatment as usual” (TAU). The content, type and the 
extent of the treatment provided were not recorded in this study. Verbal accounts from 
clinicians’ in retrospect indicate that “treatment as usual” at the clinics was not predominated 
by any particular therapeutic or theoretical approaches, but was rather chosen according to the 
individual clinicians’ competence. Both cognitive-behavioural- and psychodynamic 
approaches were used, and both individual and family-based interventions were offered. For 
anxiety disorders, there was an agreement that exposure based cognitive-behaviour therapy 
should be the treatment of choice. For the treatment of depression, cognitive- behavioural 
approaches, narrative approaches, and family-based and systemic interventions seemed to be 
treatment alternatives. For both depression and anxiety disorders, medical treatment was not 
first line treatment, but was in a few cases offered as additional treatment.  
 
Measures  
Diagnostic interview: The Schedule for Affective Disorders and Schizophrenia for 
School-Age Children-Present and Lifetime version (6-18) (K-SADS-PL) (Kaufman et al., 
1997) is a well-established semi-structured interview that assess present and past episodes of 
psychopathology according to DSM-IV criteria for axis 1 diagnosis (American Psychiatric 
Association, 2000). The interview provides DSM-IV diagnoses of a wide range of psychiatric 
disorders, and was administered by a trained professional to a primary caregiver and to the 
child/adolescent.  
In the studies of the present dissertation, we only addressed the present episode of 
psychopathology. The administration of the K-SADS includes a short background interview 
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(including anamnestic information), a screening interview, targeted supplemental interviews if 
indicated by the screening, and assessing the diagnostic scheme. Most symptoms are 
evaluated on a scale from 0 (no information), to 1 (not present) through 3 (clinical threshold). 
Both probes and objective information is used to rate individual symptoms. After the 
screening interview, the clinician evaluates if further assessment is indicated through targeted 
supplements. Each supplement has a list of symptoms, probes, and criteria to assess current 
and the most severe past episodes of disorder. The summary diagnostic information is 
evaluated through the synthesis of the data from all sources. The following diagnosis was of 
interest in the present study: Major Depression, Dysthymia, Depressive disorder NOS, 
Adjustment disorders with depressed mood, Panic Disorder, Separation Anxiety Disorder, 
Simple Phobia, Social Phobia, Agoraphobia, Generalized Anxiety, Adjustment disorders with 
Anxiety, Obsessive Compulsive Disorder, Post-Traumatic Stress Disorder, and Acute Stress 
Disorder. The psychometric evidence for the Norwegian K-SADS-PL is limited. A review (H. 
S. Kornør, G., 2016) conclude that excellent inter-rater reliability for central diagnostic 
groups support clinical usage of the instrument by qualified health personnel. 
For our sample the most common supplements were: 1. Affective disorders (n= 29), 
and/or supplement 3. Anxiety disorders (n = 34). Other supplements conducted in this sample 
were: Supplement 4. Behavioural disorders (n = 18), Supplement 5. Drug abuse and other 
disorders (n = 5), and Supplement 2. Psychotic disorders (n = 2).  
 
The Health of the Nation Outcome Scale (HONOSCA): The HONOSCA is a 15-item 
clinician rated measure of mental health symptoms, and it was developed to evaluate 
treatment in child and adolescent mental health services (CAMHS) (Gowers et al., 1999). The 
HONOSCA have moderate to good inter-rater reliability (Brann, Coleman, & Luk, 2001;  
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Gowers et al., 1999; Hanssen-Bauer, Gowers, et al., 2007), acceptable validity (Bilenberg, 
2003; Brann et al., 2001; Garralda, Yates, & Higginson, 2000; S. G. Gowers et al., 1999; 
Manderson & McCune, 2003), and is sensitive to change in clinical populations (Brann & 
Coleman, 2010; Brann et al., 2001; Holzer et al., 2006; Kisely, Campbell, Cartwright, Cox, & 
Campbell, 2010; Kisely, Campbell, Crossman, Gleich, & Campbell, 2007). The HONOSCA 
total score has proven as a good quantitative measure of clinical severity (Brann et al., 2001; 
S. G. Gowers et al., 1999) and correlates well with the CGAS (Lundh et al., 2013; Wolpert, 
2008). In this study, the sum score of the first 13 scales, the total score (range 0 – 52), was 
used to assess the overall severity of mental health problems, as well as change in the overall 
severity over time. The scoring of the HONOSCA is based on the information that the 
clinicians have about the client, and is not the result of a specific interview or a specific 
assessment. The clinician is instructed to rate the items based on the most severe occurrence 
relevant for each scale for the past 2 weeks. Scores of 2 considered as the clinical cut-off. 
There is no clinical cut-off for the total score. Cronbach’s α for the HONOSCA total score at 
intake was 0.52 for the current sample.  
 
The Childrens’ Global Assessment Scale (CGAS): The CGAS (Shaffer et al., 1983) is 
a uni-dimensional, clinician rated score of general psychosocial functioning for children and 
adolescent between 4-16 years, in the range from 0 (needs constant supervision) to 100 
(superior functioning in all areas). In the study of the present dissertation, the most impaired 
level of functioning for the last month was rated. The clinician rates the CGAS based on a 
broad range of clinical data regarding the child and adolescent symptomatology and 
behaviour at home, in school and in social activities. The inter-rater reliability of the CGAS in 
comparable studies, have shown intra-class correlation (ICC) of ICC = 0.61 (Hanssen-Bauer, 
Aalen, Ruud, & Heyerdahl, 2007) and ICC = 0.73 (A. Lundh, Kowalski, Sundberg, Gumpert, 
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& Landen, 2010), which according to the standards presented in Shrout (1998) correspond to 
moderate reliability. In the study of the present dissertation, only one rater had scored the 
CGAS and therefore the ICC could not be calculated. The CGAS has been used as one “gold 
standard” for psychosocial functioning when validating other instruments (Schorre & 
Vandvik, 2004). National normative data have not been collected for the CGAS (Winters, 
Collett, & Myers, 2005). The CGAS threshold between 61 to 70 has been found to best 
distinguish cases from non-cases (Bird et al., 1988; Bird et al., 1990). Scores below 61 was 
considered a “definite” case, while scores between 61 and 70 were considered a “possible” or 
“probable” case, and scores above 70 were considered non-cases. A cut-off score of 70 have 
been shown to differentiate normal functioning from problems in need of treatment also in a 
German study (Steinhausen, 1987). 
 
The Strenghts and Difficulties Questionnaire (SDQ): The SDQ (Goodman, 1997) has 
become a widely used tool for the screening of mental health symptoms, peer relations, 
prosocial behavior and functional impairment. The characteristics of the SDQ, as well as 
studies on the psychometric properties, are presented in the Methods section of paper 2. Some 
information is added here. The SDQ total score is considered a usefulness outcome measure 
(Mathai, Anderson, & Bourne, 2003; Vostanis, 2006), and a reasonable compliment to the 
HONOSCA (Mathai et al., 2003). The impact score has been described as a reliable and easily 
obtained measure of change over time (Stringaris & Goodman, 2013). The psychometric 
properties of the Norwegian self-report SDQ (SDQS) have been evaluated (Kornør & 
Heyerdahl, 2013). The review concludes that the SDQ is uncertain as a screening instrument, 
national norms are lacking, the internal consistencies of all scales are below adequate levels 
(except for the emotional problem scale), and the construct validity is acceptable. The parent 
version is currently being reviewed.  
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The HONOSCA, CGAS and SDQ as change measures 
Along with the HONOSCA and the CGAS, the parent- and youth-reported SDQ 
(Goodman, 1997) is extensively used in CAMHS (Wolpert, 2008) as a measure of both 
symptom severity, domain specific severity and a separate measure of the impact of problems. 
In three studies, change in the HONOSCA was shown to be comparable in magnitude and 
direction with the Children’s Global assessment scale (CGAS) (Bilenberg, 2003; Garralda et 
al., 2000; Gowers, Levine, Bailey-Rogers, Shore, & Burhouse, 2002), and to a lesser extent 
with the parent-rated Strengths and Difficulties Questionnaire (SDQ). To evaluate service 
level outcomes the CORC recommends the SDQ to be used alongside with e.g. goal based 
measures, measures that are more specific to the presenting difficulties, and HONOSCA and 
CGAS representing the clinician perspective (Wolpert, 2008). A more recent review of the 
clinical use of the SDQ self-report version conclude that its utility as a feedback measure is 
unclear, and that the general scope of the SDQ makes is perceived by clinicians as less 
relevant for individual clients (Wolpert, Cheng, et al., 2015). 
 
Reliability 
Clinicians trained and experienced with the Kiddie SADS conducted the interviews. 
The clinicians attended courses in conducting the Kiddie-SADS PL, and received supervision 
regarding the use of the interview during the study period. Inter-rater reliability tests were not 
done in the clinics.  
Clinicians were offered training in the scoring of the HONOSCA and CGAS at several 
occasions during the project period. The training consisted in the scoring of vignettes 
followed by discussion aimed at reaching consensus of the scoring. In table 2, descriptive data 
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for the clinicians’ account of training and experience with completing the HONOSCA and 
CGAS is presented. Unfortunately, the ICC was not calculated for the scored vignettes during 
the training. Clinicians from the CAMHS Alta participated in the study by Hanssen-Bauer, 
Aalen, Ruud and Heyerdahl (2007). The ICC for the HONOSCA total score was 0.81 (single 
scales 0.47 – 0.96) and for the CGAS was 0.61. The ICC for the 10 clinics participating in the 
study was not reported separately, but there were not statistically significant differences in the 
ICC between clinics. The raters profession or experience did not influence the scores in this 
study. Recently, Ketil Hanssen-Bauer calculated the ICC for the clinicians participating from 
the CAMHS Alta on my request. A total of eight clinicians rated the HONOSCA total score 
(ICC = 0.80) and four of the clinicians rated the CGAS (ICC = 0.55), while the remaining 
four clinicians rated the Global Assessment of Psychosocial Disability (GAPD).  
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Table 1: Descriptive data for the clinicians account of their experience with the 
HONOSCA/CGAS 
 T0 assessment 
% (n) n = 73 
T1 assessment 
% (n) n = 71 
T2 assessment 
% (n) n = 57 
 yes no yes no yes no 
HONOSCA/CGAS 
training 
72.6 (61) 14.3 (12) 57.1 (48) 27.4 (23) 54.8 (46) 13.1 (11) 
Completed/ 
handed in scored 
test vignettes 




7.1 (6) 81 (68) 3.6 (3) 79.8 (67) 1.2 (1) 66.7 (56) 
No of HONOSCA/ 
CGAS scorings 
   
 0-5 11.1 (10) 16.7 (14) - 
6-10 13.1 (11) 16.7 (14) 2.4 (2) 
11-15 7.1 (6) 17.9 (15) 13.1 (11) 
16 – 20 8.3 (7) 11.9 (10) 17.9 (15) 
>20  46.4 (39) 19 (16) 34.5 (29) 
 
Handling of missing data 
The term missing data refers to an intended measurement that could not be obtained. 
Missing data in longitudinal studies may result in unbalanced data over time, in a loss of 
information and may cause a reduction in the precision of variable estimates (Fitzmaurice, 
2004). By using the Mixed Models approach, some of the problems with missing data can be 
accounted for since this method allows for the inclusion of subjects with missing data. A 
presumption for the use of the mixed models approach is that data must at least be missing at 
random (MAR), (i.e., missing data is related to an observed variable, but not to the variable of 
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interest) and preferably also be missing completely at random (MCAR), (i.e., missing data is 
unrelated to any other variable in the study).  
In the studies of the present dissertation, missing data includes both missing 
information for variables tested as predictors, and also missing data for the repeated measures. 
There is a difference between the CAMHS clinics, where CAMHS Alta have considerably 
more complete data both for predictor variables, and for the repeated questionnaires at 
baseline and at follow-up for all the different measures. A flow-chart of participants was 
presented in Figures 1 (clinician rated Health of the Nation Outcome Scale - HONOSCA) and 
2 (clinician rated Children’s’ Global Assessment Scale - CGAS) in paper 3, and available data 
for all the change measures were presented in Table 1 of paper 2 and 3. The amount of 
follow-up data for the clinician rated measures was acceptable (CGAS 61 % and HONOSCA 
73 %), while the amount of follow-up data for the child- and parent-rated measures was 
problematic (SDQS N = 20, 32 %; SDQM N= 24, 31 %; SDQF N= 12, 24 %). In paper 2 the 
SDQ was used as a measure of change despite this limitations, while in paper 3 the amount of 
data for predictor-outcome pairings were too small to conduct reliable analyses. Inclusion of 
predictor-outcome pairings with small sample sizes could have resulted in low accuracy of the 
parameter estimates of those pairings (Kahn, 2011). As a consequence, SDQ was removed as 
a change measure in paper 3, and predictor-outcome evaluations were performed on the 
clinician rated measures only. For the preparation of paper 3, I counted predictor –outcome 
pairings to evaluate which predictors that had a reasonable amount of data. First, I calculated 
the maximum amount of available data for the HONOSCA (n = 80; 3 x 80 = 240 
measurement occasions in total), and for the CGAS (n = 82; 3 x 82 = 246). Next, available 
data concerning pre-treatment characteristics of the child was counted. When preparing for 
paper 3, several potential predictors were available and relevant, but could not be tested due to 
low proportions of predictor –outcome pairings. The variables omitted due to missing data 
 37 
were: Intelligence Quotient (IQ) from the Wechsler Intelligence Scale III (Full scale IQ, 
Verbal IQ and Performance IQ), having learning difficulties (yes/no), experience with 
physical or sexual abuse (yes/no), SDQ-item regarding duration of problems (mother- or self-
report), being in contact with child protective service (yes/no), being under the care of child 
protective service (yes/no). 
The mixed models approach do have the advantage that subjects are not omitted from 
the analysis with missing data. Regarding estimates of the rate of change, the individuals with 
data on all three measurements occasions will contribute the most information for the 
estimation of change rates (slopes) at the group level, individuals with data on two 
measurement occasions will contribute with some information, while individuals with data on 
one occasion do not contribute to the estimation of change rates. The representativeness of the 
estimated change rate depends on the proportion of individuals with data for at least two 
measurement occasions. 
		
Selection procedure and inter-rater agreement:  
Due to the problem of missing data, we had to rely on different selection procedures to 
identify the greatest number of relevant cases. First, we used the Kiddie-SADS interview to 
identify children and youth that fulfilled the criteria for a diagnosis of unipolar depression 
and/or a diagnosis of one or several anxiety disorder (n = 57). Two raters, Toril Sørheim 
Nilsen and Siv Kvernmo, rated all the interviews independently. Bjørn Helge Handegård, 
calculated the inter-rater agreement. The Gwet’s AC2 per disorder is presented in Table A4 
(supplemental material of paper 3, see Appendix 2). Gwet’s AC2 was used to assess inter-
rater agreement since it has been shown to provide more stable inter-rater agreement 
coefficients (Gwet, 2008; Wongpakaran, Wongpakaran, Wedding, & Gwet, 2013). The inter-
rater agreement, as measured by Gwet’s AC2 ranged from 0.90 (Major depression) to 0.99 
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(Panic Disorder), which according to Landis and Koch (1977) agreement criteria correspond 
to the range of “almost perfect” agreement (0.81-1.00). It is important to note that Landis and 
Koch (1977) presents their divisions as arbitrary, but useful benchmarks of agreement. There 
is ongoing debate about the use of such cut-offs (e.g Hallgren, 2012).   
Furthermore, cases with disparate ratings were discussed and consensus based 
diagnoses were set. Finally, cases with missing data for the Kiddie-SADS, but with a 
registered axis 1 diagnosis of depression and/or anxiety, were selected (n = 27). In the clinics, 




Research on child and adolescent patients may be one of the fields that require the 
most careful reflections on ethical issues. The Regional Committee for Medical Research 
Ethics (REK), and the Norwegian Social Science Data Services approved the study. The 
project was evaluated to involve minimal risk, to provide knowledge of vital importance that 
could not be obtained by studying other groups, and to have a favourable risk/benefit ratio. 
These issues were evaluated regularly throughout the project period. Although the study was 
approved by the REK, this does not guarantee that ethical pitfalls and dilemmas may not arise 
during the project, some being out of the control and some out of the awareness of the clinical 
researcher.  
Informed consent is standard in all medical research, and in the case of research where 
children are participants require special attention. Before inclusion in the CAMHS North 
study, written consent was obtained at intake. For children < 12 years, both parents or 
caregivers consented. Adolescents between 12 and 16 consented together with their 
 39 
parents/caregivers. Adolescents > 16 could consent themselves. Information about the 
research project was given both orally and in writing during the intake meeting at the clinics. 
Unfortunately, the total number of individuals asked to participate and the number of refusals 
was not recorded. According to verbal accounts from the staff, very few individuals refused to 
participate. Refusal to participate in the study did not affect the service offered, and 
nonparticipants were assessed and treated through the same procedures as study participants.   
 
Statistical analysis of paper 2 and 3  
The statistical analyses in paper 2 and 3 were performed using Statistical Package for 
the Social Sciences (SPSS) version 22. Longitudinal multilevel analysis, also known as the 
mixed models approach, was used in paper 2 and 3 to evaluate the research question 1 and 2 
(paper 2) and research question 1 (paper 3). Further descriptions of the use of the mixed 
models approach for the specific research questions are presented in the Methods sections of 
paper 2 and 3.   
The reliable change index (RCI) is a statistics estimating if changes in psychometric 
measures may represent real change or occur by measurement error (Jacobson & Truax, 
1991). The reliable change index (RCI) is a simple statistical computation, which estimate if 
changes in two psychometric measures are probably due to measurement error or can be 
accounted by other factor, such as a clinical intervention. The RCI index it's a useful method 
to assess if changes in psychometric measures may represent real change or occur by 
measurement error. When evaluating change from the perspective of clinical significance we 
adopted the account of Jacobson and Truax (1991). In their two-fold method, individual 
patients’ response to treatment is evaluated both according to statistical reliability and clinical 
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significance. For further description of the use of this approach in our study is presented in 
paper 2.  
Definitions of the different parameters of the multilevel analysis are presented in Table 
10 of the Supplemental material of paper 3 (see Appendix 2).   
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Summary of papers  
Paper I 
Predictors and moderators of outcome in child and adolescent anxiety and depression: a 
systematic review of psychological treatment studies. 
Analyses and results 
A literature search was performed using several databases, and resulted in 44 published 
studies (32 anxiety studies and 12 depression studies) meeting predefined methodological 
criteria. Ten client demographic- (age, gender, ethnicity, IQ) and clinical factors (duration, 
type of diagnosis, pre - treatment severity, comorbidity) were examined across studies. None 
of the pre-treatment demographic variables were found to consistently predict or moderate 
treatment outcome. Higher levels of baseline symptomatic severity were associated with 
worse outcome in several anxiety and depression treatment trials. There was also some 




The lack of association between demographic variables and treatment outcome was the 
most consistent finding across studies. Several interpretations of the finding were offered. 
Firstly, one plausible interpretation could be that psychosocial treatments for anxiety and 
depression in children and youths are equally effective for boys and girls, and for young 
children and adolescents. Secondly, most studies relied on small samples and this may have 
hindered the detection of small to medium effects. 
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Baseline symptom severity (3 of 4 studies) were negative prognostics for depression 
treatment outcome, while for the anxiety treatment studies this was found in a smaller 
proportion of studies (2 of 6 studies). Several interpretations of the findings were offered. 
Firstly, the apparent difference in the impact of the severity factor for anxiety and depression 
may be due to characteristics of the anxiety treatment studies, namely that the samples in the 
anxiety treatment studies were too homogenous in relation to the severity range that it was not 
possible to detect any effects. Another interpretation was that children and adolescents with 
more severe levels of depression might benefit more from a combination treatment with 
psychosocial treatment and medication. 
Findings related to the impact of comorbidity showed that general comorbidity and 
externalizing comorbidity were not associated with differences in treatment response, whereas 
the results for internalizing comorbidity was mixed. Depressive disorder with comorbid 
anxiety disorder had a more negative treatment prognosis in two out of five studies, while 
anxiety disorder with comorbid depression was related to worse treatment outcome in two out 
of nine studies. The findings regarding internalizing comorbidity was regarded as 
inconclusive, and it was pointed out that the lack of findings and the mixed results may also 
be due to characteristics of the extant treatment studies considering this topic. 
To progress in the understanding of the factors that impact treatment response, some 
future directions based on the extant research literature point to the need for prioritizing the 
study of predictors and moderators of treatment response, of adapting a more programmatic 
approach with a common conceptual framework and common measurement practices, and on 




Evaluating change in symptomatic and functional level of children and youth with 
emotional disorders: a naturalistic observation study.  
Analyses and results 
Changes in symptomatic and functional impairment for children and youth with 
emotional disorders treated at child and adolescent mental health outpatient services 
(CAMHS) in Norway, was evaluated by means of statistically significant change, by 
comparison with waitlist control, and through calculation of clinical significant change. The 
results show that children and youth with emotional disorders experience a statistically 
significant improvement per month during outpatient treatment according to nearly all the 
measures of change. The only exception was change in parent rated functional impairment, 
which was not statistically significant. For the clinician rated scores, change rates during 
active assessment/treatment were larger than during the waitlist period. Evaluating change 
from the perspective of clinical significance showed that only a small proportion of the 
subjects had change scores that were statistically reliable and clinically significant. Whether 
an actual change has occurred is uncertain for the majority of patients. 
Discussion  
Statistically significant improvement according to nearly all measures, together with 
elevated change rates of the clinician rated measures in the active assessment/treatment period 
as compared to the waitlist period, may give an impression of positive effects during CAMHS 
treatment. Still, any conclusion regarding the relative effect of the CAMHS intervention is 
limited due to the lack of a control group. Alternative explanations of the positive effects can 
be regression toward the mean (RTM), the tendency for high baseline scores to follow a 
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reductionist path, and of the active assessment/treatment period being on average longer than 
the waitlist period.  
Evaluating change from the perspective of clinical significance showed that for the 
majority of patients the amount of change experienced is not sufficient to be classified as 
“recovered” or “improved”, and for the majority the degree of change must be classified as 
“uncertain”. Also, the difference in the clinician, adolescent and parent account of change 
became apparent through this approach to the evaluation of change. The evaluation of change 
from the perspective of clinical significance adds valuable clinical information at the 
individual level. The usage of broad measure may partly explain the uncertainty of change 
seen in the majority of subjects. Changes may have been more pronounced if we had included 
more disorder specific measures.  
 
Paper 3 
Predictors of rate of change for children and youth with emotional disorders: a 
naturalistic observational study.  
Analyses and results 
Longitudinal multilevel analyses were performed to examine demographic and clinical 
characteristics as potential predictors of change for children and youth with emotional 
disorders. For the HONOSCA total score, youths with a diagnosis of depression had 
statistically higher symptom severity levels at baseline and significantly lower change rates as 
compared to youths with anxiety disorders. For the CGAS, a difference was found between 
the clinics in the level of functional impairment at baseline, as well as in the CGAS rate of 




The significant difference in baseline CGAS scores between the two clinics, as well as 
the significant difference in CGAS rate of change may reflect actual differences in the patient 
groups of the two clinics, it may reflect RTM since the clinic with the lowest CGAS also had 
a steeper rate of change, and it may reflect differences between the clinics in the way the 
CGAS is interpreted and scored.  
The finding that children and adolescents with a diagnosis of depression were rated as 
having higher total symptom severity at baseline and to experience less change when 
compared to children with anxiety disorders, may be interpreted as a replication of findings 
from other studies showing that anxiety disordered youth are more likely to recover if treated.  
There were no associations between demographic factors and rate of change, which is 
in line with the extant research literature. The finding may reflect that the service function 
equally well for boys and girls and for different age groups. Missing data on follow-up 
measures as well as the low number of participants in this study may be one reason for not 




This thesis sought to expand our knowledge concerning change during CAMHS 
treatment for children and adolescent with emotional disorders, and concerning pre-treatment 
demographic or clinical characteristics of the child as potential predictors of change. I will 
discuss the main findings of the studies. Alternative interpretations of the presented results 
and methodological issues that may impact the interpretation of the findings are highlighted. 
Also, suggestions for future directions for clinical care and research in clinical settings are 
discussed.  
 
Outcomes in CAMHS 
Different approaches may lead to different conclusions regarding the outcomes, an 
observation reported in paper 2, and from Child Outcomes Research Consortium (CORC) 
data (M. Wolpert, Goerzig, et al., 2015). In our study, results at the group level gave an 
impression of positive outcomes since statistically a significant improvement was found at the 
group level for the great majority of change measures (Paper 2). The effect sizes, as calculated 
through the pseudo-R², showed small effects, and waitlist control data indicated that change in 
clinician-rated measures seem to be larger during active treatment. As presented in the 
introduction, results from large-scale naturalistic observational studies show significant 
improvement in mental health outcomes after CAMHS treatment with overall modest effects 
(e.g Fugard et al., 2015; M. Wolpert et al., 2012; M. Wolpert, Goerzig, et al., 2015).  
The lack of a control group limits conclusions regarding the relative effect of the 
CAMHS interventions in our study, as well as in other naturalistic observational studies. The 
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limitations related to the inference of results in treatment studies that are not randomized 
controlled trials (RCT) are several. Factors such as spontaneous recovery or the natural 
history of a disorder (W. Lambert & Bickman, 2004), the tendency for cases to be referred 
when problems are at peak followed by regression toward the mean (RTM), improvements in 
score due to repeated questioning, are all factors known to impact outcomes. In the absence of 
a control group it is methodologically challenging to rule out regression towards the mean 
(RTM) from the overall results, and removing RTM has been associated with a large decrease 
in effect size (Iachina & Bilenberg, 2012).  
Evaluating change from the perspective of clinical significance added important 
information for the interpretation of findings in our study. It is a common observation that 
evaluations by means of clinically significant change yield a more modest account of the 
effectiveness of treatments than what is implied by standard statistical comparisons (Jacobson 
& Truax, 1991). Our results concerning clinical significant change did not allow an optimistic 
view since very few individuals could be classified as recovered, improved or both, according 
to the more conservative account of clinical significant change. For the majority of children, 
the size of the change score during assessment and treatment was either too small to be 
regarded as reliable, or did not move from the clinical range into the normal range. Thus, as 
concluded in paper 2, the amount of change registered while in CAMHS treatment was clearly 
questionable for the majority of subjects. It was uncertain whether the differences in pre-post 
scores for the majority of individuals reflect change beyond arbitrary fluctuations of the 
instruments. The finding of few individuals obtaining clinical significant change is in line 
with treatment outcome studies and meta-analysis of usual care suggesting little improvement 
associated with such services (Garland et al., 2013; Warren et al., 2009; Weisz, 2004; Weisz, 
Donenberg, Han, & Weiss, 1995). As summarized by Fuggle (2015), large scale studies of 
usual care from the United Kingdom and the United States suggest that complete remission of 
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a presenting problem will occur in a minority of children around 15-20 %, that 25-30 % will 
not improve, while between 2 and 10 % get worse during usual care. Clearly, the proportion 
of individuals in our study with clinical significant change was considerably lower than what 
has been reported in other studies of clinician-rated outcomes (L Bickman, 2008; Day & 
Davis, 2006; Fuggle, 2015), and studies reporting results on parent rated change (e.g 
Edbrooke-Childs, Jacob, Law, Deighton, & Wolpert, 2015; Warren et al., 2009; M. Wolpert, 
Goerzig, et al., 2015).  
How can these results be interpreted? Is the outcome of the CAMHS service in our 
study, as well as in other studies of usual care, really that questionable? Some methodological 
limitations of our study and of other comparable studies, may partly explain the lack of 
change observed. Firstly, choice of change measures to be used may impact the results. The 
use of broad change measures in our study, as well as within the CORC (e.g. M. Wolpert, 
Goerzig, et al., 2015) and other large scale studies (Manteuffel et al., 2008), may result in less 
pronounced changes due to the general scope of the questionnaire. More problem-specific 
measures have been found to yield larger effects than broader measures (Lee, Jones, 
Goodman, & Heyman, 2005), as well as the use of goal-based outcomes (Edbrooke-Childs et 
al., 2015). For our study, changes could have been more pronounced if we had included 
measures of symptomatic change in anxiety and depression. Although we did evaluate change 
in the SDQ emotional problem scale in order to assess change in a more specific and relevant 
domain, the items of the SDQ emotional problem scale are not disorder-specific and are 
considered a broad measure of emotional problems (Lee et al., 2005).  
Secondly, small effects related to usual care may also be explained by the fact that 
many studies rely on a limited number of outcome domains, which may underestimate the 
number of youth that may have improved after treatment, a point made by Brookman-Frazee, 
Haine, and Garland (2006). Traditionally, the outcome domains most often studied, are 
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changes in general symptomatic- and functional impairment levels, in disorder specific 
symptom levels or in diagnostic status. In one study from the CORC, 77 % of parents reported 
reliable improvement in progression towards goals, while the corresponding number for 
reliable improvement was 53 % for the SDQ impact scale and 18 % for the SDQ total score 
(Edbrooke-Childs et al., 2015). Thus, the choice of outcome domain clearly may affect the 
amount of change observed. In this study, both change in progress towards goals and in the 
impact score corresponded to large effects, while changes in total severity corresponded to a 
medium effect. For several groups of children receiving care, symptomatic change may not be 
pronounced and the evaluation of change in other domains, such as coping skills, may be a 
more appropriate target (Batty et al., 2013). 
Thirdly, the modest effects and the few individuals with clinical significant 
improvement may be partly explained by relatively low baseline SDQ, and baseline CGAS 
scores when compared to clinical cut-offs. Thus, the range for improvement was limited at the 
outset. The HONOSCA has no cut-off for the total score. For the CGAS, a cut-off score of 70 
has been shown to differentiate normal functioning from problems in need of treatment 
(Steinhausen, 1987). In our study the Mean CGAS at baseline was 64.03. According to British 
SDQ norms, the Mean self-reported total score and emotional problem score at baseline is in 
the upper normal range, while parent-rated total scores and emotional problem score 
correspond to the borderline range. Screening scores in the normal and borderline range at the 
outset could raise the question of whether the sample is sufficiently impaired to be in 
specialized care. As stated in the discussion in paper 2 concerning the SDQ, the general 
British norms may not be well suited for a Norwegian clinical sample. To be sufficiently 
precise, norm data should present adjusted cut-off scores for age groups and gender 
(Goodman, 1997) and more culture specific norms (Obel et al., 2004). Parents and teachers 
from Scandinavian countries tend to rate lower scores on symptom scales and tend to under-
 50 
recognize emotional problems in children and adolescents (Heiervang et al., 2008). A possible 
explanation is that Nordic adults must observe a higher intensity and frequency of symptoms 
before endorsing a corresponding item. Also, results from the CAMHS North study indicate 
that the usefulness of the SDQ scoring algorithm (based on British norms) in detecting mental 
health disorders, was only partly supported, the SDQ was considered as not sufficient for 
clinical purposes, and emotional disorders had the lowest sensitivity (Brøndbo et al., 2011). 
The clinician assigned diagnosis (based on the Development and Well-Being Assessment) 
was higher than the “probable” screening rate for emotional disorders based on the parent- 
and self-reported SDQ. I have not managed to find studies evaluating the SDQ as a screening 
instrument in relation to the Kiddie-SADS PL. As for the CGAS, the relatively high baseline 
score may reflect that problems in functioning were not fully recognized in the first intake 
meeting, and ratings may have been influenced by limited information. As noted in Winters, 
Collett, and Myers (2005) the global scope of the CGAS, the mixture of objective and 
subjective descriptions, and the considerable time needed to gather all relevant information 
may be relevant disadvantages of the CGAS when the score is used to make judgements about 
the eligibility to services.  
Fourthly, the problem of missing follow-up data for the SDQ poses a serious threat to 
the validity of the result for self- and parent-rated change estimates. Thus, a clear limitations 
of our study is that the clinician rated measures were the only outcome data with acceptable 
follow-up rates, which is problematic since the clinician also is the provider of the treatment, 
and may be a biased observer of client status and client change (Bilsker & Goldner, 2002). 
Another objection against using the clinician perspective is that ratings are often based on 
reported instead of observed symptoms or difficulties (Wolpert, 2008). In our study, clinicians 
were aware of the children’s status in treatment, which may have influenced the ratings of the 
waitlist period as compared to the active assessment/treatment period. As stated by 
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Brookman-Frazee et al (2006), limited effects in usual care may also be explained by the 
reliance on a limited number of informant perspectives in many studies, with the potential loss 
of information regarding change during treatment. Clearly, the clinician-rated perspective is 
only one point of view and possibly a biased one. The clinician perspective is important from 
a multi-informant perspective, but should not be the only perspective on change (Fuggle, 
2015). In our study, it would have been a clear advantage if the SDQ data where more 
complete, both in order to evaluate change from different perspectives and to gain knowledge 
of agreement/disagreement concerning change. Having access to data or ratings from a more 
objective observer perspective would also have been a valuable source of information 
regarding change during CAMHS treatment. 
The problem of missing follow-up data is well known in naturalistic observational 
studies in clinical settings (e.g Baruch & Vrouva, 2010) and may comprise inferences about 
the effectiveness of the service, the reliability of the results, and the generalizability of the 
findings. To compare, within the CORC database that have been built up over a decade only 
24 % of cases have meaningful outcome data (Fleming, Jones, Bradley, & Wolpert, 2016). 
The high proportion of missing follow-up data is a concern although the rate of outcome data 
has improved over the years (Hall et al., 2013). The CORC reports a situation similar to the 
present study, namely that measures completed by the clinician are more frequent than 
measures completed by the service users and that the HONOSCA was the measure that was 
most often used, followed by the CGAS (Batty et al., 2013; Hall et al., 2014). This was also 
the case in the present study.  
Thus, what can be inferred about the effectiveness of CAMHS service for children and 
adolescents with emotional disorders in two Norwegian CAMHS? Clearly, as the discussion 
concerning the methodological limitations suggests, any inference will be subject to several 
reservations. The main finding concerning change during CAMHS treatment is that the 
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amount of change in total severity and functional impairment is clearly questionable for the 
majority of subjects. It is uncertain whether the differences in pre-post scores reflect change 
beyond arbitrary fluctuations of the instruments, which underlines the importance of 
continuing efforts to improve data quality of routine outcome measurement and to continue 
the evaluation of clinical outcomes of the CAMHS service. The results also call for quality 
improvement of the service provided for this group of children. Suggestions for actions to 
improve both quality improvements of the service and of routine outcome measurement will 
be further elaborated on in the  ”Future directions for clinical practice and research in clinical 
settings” section. 
 
Differences in baseline CGAS and in CGAS rate of change 
The sample at CAMHS Silsand was rated as more functionally impaired at baseline 
and had a significantly higher CGAS rate of change than the sample at CAMHS Alta. The 
clinics did not differ regarding the corresponding HONOSCA scores. Is this an actual 
difference between the two clinics in the level of functional impairment of their respective 
patient groups and also a difference in the rate of change for the samples? How can this 
finding be interpreted? Several alternative explanations are plausible. There may be a real 
difference in the quality of the services that might result in improved change rates. Also, the 
finding of higher pre-treatment functional impairment followed by a higher rate of change 
may reflect what is known as regression towards the mean (RTM), the tendency for high 
initial scores to follow a reductionist path and being closer to the mean at follow-up (Kane, 
2006).  
It is recommended that no ranking and no comparison between clinics should be done 
without careful investigation of the local context that may influence results (Fugard et al., 
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2015). Thus, characteristics of the two clinics, such as staff competence, caseload, turnover, 
working environment, may have influenced the results. One important difference between the 
clinics was that the CAMHS Alta had a larger sample, and had better data quality with less 
missing data in comparison with the CAMHS Silsand data. Some evidence suggest that 
service users with poorer outcomes are less likely to respond to follow-up measures (Clark, 
Fairburn, & Wessely, 2008), which can lead to inflated outcomes. This may result in a 
situation where services that succeed in collecting more complete follow-up data can get more 
modest accounts of change. 
Also, the comparison of pre-post scores between clinics is not recommended since 
such information is always influenced by factors such as case-mix, sample-size etc. One study 
of case-mix adjustment, suggests that the important variables that relate to outcome 
differences among clinics have yet to be identified, and that the reasons for the differing rates 
of success between clinics are not currently known (Ogles, Carlson, Hatfield, & Karpenko, 
2008). Parent-rated severity at baseline was the one case-mix variable that changed the rank 
order of clinics. High pre-treatment severity was associated with more change and adjusting 
for this variable changed the ranking of some clinics. In Table S1 of Appendix 2 
(supplemental material of Paper 3) the descriptive information for the samples of the two 
clinics is presented separately. The CAMHS Silsand sample consisted of 26 individuals, and 
the case mix differed from the larger CAMHS Alta sample (n = 56) in respect to age 
distribution (majority in the 13-18 age group), gender composition (near 50 % boys), and 
diagnostic grouping (half of the sample with depression). There may be some characteristics 
of the case mix and sample characteristics that could have influenced the results. The lower 
baseline CGAS and the higher CGAS rate of change of CAMHS Silsand may correspond to 
the observation reported by Ogles et al (2008) of higher pre-treatment severity associated with 
higher rates of change. As described previously, in the mixed models approach, individuals 
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with more complete data contribute more to the estimated change rate (slope) than individuals 
with less data. The proportion of individuals with data on two or more measurement occasions 
will determine the strength or representativeness of the estimates. For the sample of 26 
individuals, only 14 individuals contributed to estimated rates of change.   
The clinicians´ account of prior experience and training in the HONOSCA and CGAS 
may be important to consider when interpreting the results. Lundh et al. (2010) found 
moderate inter-rater reliability (ICC = 0.73) when the CGAS was used by professionals 
without prior training in the use of the instrument, while the ICC of a group of five 
experienced raters was 0.92. Compared to the experienced raters, the health-care professionals 
rated the vignettes significantly higher than the experienced raters. In the same study, clinical 
experience and prior experience of using the CGAS among the health-care professionals did 
not influence agreement with expert ratings. It is argued that proper training is important 
when introducing new rating scales. Clinicians’ account of their experience with the scoring 
of the HONOSCA and CGAS was presented in Table 2 for both clinics. I also looked at the 
descriptive data of the clinicians’ accounts for the two clinics separately and found no 
differences in the clinicians reporting about training, scoring of vignettes, or the number of 
HONOSCA/CGAS ratings. Apparently, there were no obvious differences in the clinicians’ 
account of training or experience to explain differences in CGAS ratings between the clinics. 
The inter-rater reliability of the CGAS (ICC = 0.61) corresponds to moderate/fair 
agreement, and has been found both in a study from 10 Norwegian CAMHS and in a large 
international study (Hanssen-Bauer, Aalen, et al., 2007; Hanssen-Bauer, Gowers, et al., 2007). 
Thus, differences between the clinics may also reflect local differences at the two clinics in 
how the CGAS scale is implemented and scored rather than an actual difference between 
baseline levels and rate of change of the patient groups in the two clinics.  
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Predictors and moderators of change 
None of the demographic variables was associated with differences in treatment 
change, a finding in the majority of studies included in the literature review, as well as in our 
study. The lack of association between demographic factors such as gender and age and 
change during treatment is also reported in recent treatment studies of anxiety disorders (e.g 
Compton et al., 2014; Emslie et al., 2011; Hudson, Keers, et al., 2015; Wergeland et al., 2016) 
and in a review of psychosocial treatments of depression (Weersing et al., 2016). The few 
studies suggesting age or gender as predictors or moderators of treatment change do not show 
consistent findings. Thus, our findings together with the research literature to date suggest that 
factors such as age and gender are not associated with differential treatment change. One 
interpretation of these results could be that the psychosocial treatments for anxiety and 
depression in children and youths seem to be equally effective for girls and boys, young 
children and adolescents and across ethnic backgrounds.  
Non-significant associations between potential prognostic variables and change during 
treatment have been a main finding across studies. When looking at pre-treatment 
demographic and clinical characteristics of the child as predictors or moderators of change, 
very few variables are consistently found associated with differential treatment outcome. 
Small sample sizes may have prevented detection of effects and result in non-significant 
associations for relevant prognostic variables. Small samples were a limitation described in 
relation to our study and in relation to the majority of the treatment literature reviewed (paper 
1). In paper 1, none of the studies reviewed was originally designed to examine predictors and 
moderators. They were rather studies examining the relative efficacy of CBT and in a few 
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instances for IPT. Thus, in both paper 1 and 3, statistical analyses performed on small samples 
may partly explain the lack of effects. 
The problem of missing follow-up data, and missing information on potential predictor 
variables are other limitations that may result in difficulty in detecting effects in the studies of 
this dissertation. In paper 3, due to the problem of missing data and the small simple size, 
some of the tested predictor-moderator pairings relied on what is considered a minimum 
criterion for available data pairings in such analysis. Both the number of subjects in the 
sample as well as the available data for predictor-outcome pairings decides whether there is 
sufficient power to detect effects.  
In our study, a possible limitation when examining prognostic factors was that we had 
a relatively heterogeneous group, with an age-range between 5 to 18 years, including 
individuals with depression, anxiety or both conditions. In addition, the study sample was too 
small to allow for analysis within subgroups. Thus, our sample may have been too 
heterogeneous to be able to detect any meaningful associations between prognostic factors 
and change. A limitation noted for previous studies on predictors and moderators concerned 
an opposite limitation, namely that relatively homogenous samples (e.g. age range, ethnicity, 
symptomatic levels) have resulted in a restricted range of target variables. For the depression 
treatment studies, one important limitation when examining age as a prognostic factor is that 
age has been tested only within samples of adolescents and not across the age range from 
childhood through adolescence. The null finding may therefore be partially due to restriction 
of range (Weersing et al., 2016). The restriction of age range prevails for the youth depression 
treatment literature at large. The findings on predictors, moderators, and mediators of 
treatment effects are largely based on samples of depressed adolescents. For the anxiety 
treatment studies, the relatively small variability in anxiety levels of children in previous 
studies, and many studies with small samples, may have hindered the detection of effects. 
 57 
Several of the more recent studies on anxiety treatment are large-scale effectiveness studies 
that are both powered to detect effects and include more heterogeneous samples (e.g Compton 
et al., 2014; Hudson, Keers, et al., 2015). Another important limitation for both the depression 
and anxiety treatment literature assessing predictors and moderators is that the great majority 
of findings are drawn from trials testing the effects of CBT. Results from RCT studies about 
predictors and moderators of treatment change may not apply to naturalistic settings since 
both the treatment, the setting and client characteristics tend to differ according to some 
important characteristics (e. g Villabo, Cummings, Gere, Torgersen, & Kendall, 2013). Thus, 
this may limit the ecological validity of the findings.  
As noted in paper 1, potential predictors and moderators of treatment outcome are 
numerous. Characteristics of the parental context (marital satisfaction, psychopathology), the 
familial context (family conflict, family support, socioeconomic status, living situation), child 
characteristics (e.g. gender, age), characteristics of the therapist (e. g experience, theoretical 
orientation, emphatic skills), the treatment process (therapeutic alliance, type of treatment), 
characteristics of the service (case-mix, case load, turnover, working environment), are all 
examples of potential predictors and moderators of treatment outcome. In our study, the 
predictor variables tested were pre-treatment demographic and clinical characteristics of the 
child. Other potential predictors, such as family characteristics or characteristics of the 
treatment, were omitted due to the lack of data for those variables.  
A further limitations in the literature of both depression and anxiety treatments, is the 
somewhat restricted number of predictors that are studied systematically. Another plausible 
explanation for the finding of overall non-significant associations could be that relevant 
variables are not examined systematically yet. The types of variables studied are mainly the 
same as those studied with adults (Lundkvist-Houndoumadi et al., 2014). Developmentally 
related variables and functioning such as emerging social skills and friendship quality may be 
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relevant prognostic factors for children. In the depression treatment field, future research may 
also capitalize on advances in the field of affective neuroscience, which can help to enhance 
our understanding of prognostic factors (McMakin et al., 2012). 
 
 Higher symptom severity and lower rate of change in depression than in anxiety 
Depressed individuals were rated by clinicians as having higher symptom severity 
levels at baseline, and to experience less change in symptom severity as compared to 
individuals with anxiety disorders. Differences were not apparent in regards to functional 
impairment at baseline and in rate of change. The finding of less change in symptom severity 
for this group may be inferred by different explanations. The finding was discussed in paper 
3, and is in line with research showing that anxiety disordered youths are more likely than 
depressive youths to recover if treated. Meta-analysis of CBT have found higher remission 
rates for youth anxiety disorder (57 % for CBT and 35 % for placebo) (Cartwright-Hatton, 
Roberts, Chitsabesan, Fothergill, & Harrington, 2004; James et al., 2015), than for depression 
(48 % for CBT and 34 % to placebo) (Watanabe, Hunot, Omori, Churchill, & Furukawa, 
2007). A meta-analysis of the selective re-uptake inhibitor (SSRI) fluoxetine, showed a 
response rate of 61 % for depressed youth (50 % response to placebo) and 69 % response rate 
for anxiety disordered youth (39 % response to placebo) (Bridge et al., 2007).  
Differential change rates may be due to several factors and their interaction. The 
depressed and the anxiety disorder groups are different regarding several characteristics, such 
as gender and age distribution, as well as symptom severity level. Characteristics of the 
depressive disorder group were that 85 % are girls and 89 % were in the age group between 
13 and 18. The duration of problems was rated similarly in the two groups, but we do not 
have information about the recurrence of problems or prior episodes. As an example, in paper 
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1, we referred to one study that found interaction effects between demographic (age, gender) 
and clinical factors (severity) on treatment change. Mufson (2004) found interaction effects 
between older age and elevated symptom severity, and they found improved treatment gains 
for this group when treated with interpersonal therapy for Adolescents (IPT-A) compared to 
treatment as usual (TAU).  
Several characteristics not investigated here may have an impact on the rate of change. 
Depression is considered a motivational disorder, characterized by thoughts of hopelessness 
and helplessness. Such characteristics may influence the young person’s investment and belief 
in treatment. Also, familial-and relational problems (Garoff, Heinonen, Pesonen, & Almqvist, 
2012), adverse life events and situation are often associated with the development and 
maintenance of depression. We lack information regarding other potential differences 
between the two groups, e.g. trauma experience, family context, or the presence of other risk 
factors known for the development of the two disorders (e.g Wilkinson, 2009), which may 
also impact change during treatment. According to Thapar, Collishaw, Pine and Thapar 
(2012), the strongest risk factors for adolescent depression is a family history of depression 
and exposure to psychosocial stress. There is strong evidence that family factors are important 
for the development, maintenance and course of depression in children and adolescents, 
although few studies have investigated treatment interventions targeting the family context 
(Restifo & Bogels, 2009). Some suggest that an increased focus on the family context and on 
relationship factors may be a way to improve treatment outcome for child and adolescent 
depression treatment (e.g Garoff et al., 2012; Restifo & Bogels, 2009). As was mentioned in 
the introduction, the results comparing child-only and family interventions for depression is 
mixed, but with some findings indicating that treating parent depression may be a promising 
approach for improving adolescent depression (Gunlicks & Weissman, 2008). Questions can 
be raised as to whether such factors are addressed and resolved sufficiently for the young 
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person as part of treatment. From my own experience as a clinician working in the field, there 
is a strong consensus regarding what constitutes the best treatment for anxiety disorders, 
namely exposure-based cognitive behaviour interventions. My impression is that there is no 
strong consensus of what constitutes the best practice for depression. Cognitive behaviour 
therapy seems to the treatment of choice for many clinicians, but there appears to be a greater 
uncertainty regarding what should be done to alleviate depression. It is my impression as a 
clinician that depression is a condition that is regarded as both difficult to classify as well as 
difficult to treat.  
Several reviews and meta-analyses point to a strong need for more intervention 
research in the field of depression treatment for children and adolescents (Cox et al., 2014; 
Dolle & Schulte-Körne, 2013). In their meta-analysis, Weisz et al. (2006) found that the 
overall effects of psychotherapy for depression lagged behind the effects of psychotherapy for 
other disorders in childhood and adolescence. One conclusion from this meta-analysis is that 
there is considerable room for improvement in psychological treatments for depression. 
Compared to the anxiety literature, where several candidates mediator variables have been 
identified, the results from the depression literature suggest that more groundwork is needed 
in order to understand which mechanisms are influencing change (Chu & Harrison, 2007).  
 
Reflections on methodological issues  
Several methodological limitations have been considered in relation to the 
interpretation of the results of the studies of the present dissertation. The problem of missing 
data, small sample size, the lack of a control group, clinician bias in the reporting of change, 
the lack of information regarding relevant predictors, are methodological issues that have 
already been discussed. In the following section some further methodological limitations are 
presented and discussed.  
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Selection bias and representativeness 
The sample of children and adolescents included in this study comprises those with 
available diagnostic data, who fulfilled criteria for an anxiety and/or depressive disorder 
within a larger data set. The sample consisted of 27 depressed individuals, 38 individuals with 
anxiety disorders and 19 individuals with both anxiety and depressive disorders. In relation to 
the total sample of 273 individuals, the sample with emotional disorders constituted 30.8 %, 
which is a similar prevalence as numbers presented from the CORC database (Wolpert et al., 
2016). Also, the sample has similar gender and age distribution as reported in other studies of 
this group (see Methods section). The individuals were enrolled at the two clinics during a 
time period of 4 years. Thus, for both the total sample enrolled and for the subsample with 
emotional disorders, not all individuals referred to the centers were included in the study. For 
our study, individuals were only included if they had ratings for at least one of the change 
measures, for at least one or more measurement occasions. A potential threat to the 
representativeness issue is that there is no data available concerning how many patients were 
eligible at the outpatient clinics and concerning the characteristics of referred individuals who 
did not participate in the study.  
 
Studying anxiety and depression together versus separately 
At the outset of the study, it was an intention to study children with anxiety disorders, 
depressive disorders and the group with both disorders separately, in order to assess potential 
differences in change metrics as well as in prognostic factors. The problem of missing data 
and a small study sample hindered such intentions. There are arguments, both pros and cons, 
as to whether one should study anxiety and depression jointly (Tandon, Cardeli, & Luby, 
2009; Wilkinson, 2009). Commonalities and differences between anxiety and depression have 
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been described in the literature and in the introduction section. Even though the broad band 
classification of internalizing/externalizing dimension, or as emotional disorder, are useful 
models of psychopathology, the study of individual diagnostic categories is important and 
relevant especially for clinical services (Achenbach et al., 2016). From his review of 
internalizing disorders in children and adolescents, Wilkinson (2009) concluded that anxiety 
and depressive disorders, despite their commonalities, should be investigated as separate 
disorders. For the studies in this dissertation, it would have been a clear advantage if we could 
have addressed our research questions by studying the diagnostic groups both jointly and 
separately.  
 
Strengths of the study 
The study was of a naturalistic observational type, with few exclusion criteria, which 
may enhance the ecological validity of the findings. The measures selected in the CAMHS 
North study correspond with the measures promoted and implemented by the CORC (M. 
Wolpert, 2008) in the UK, and also with Australian clinic studies (Patterson et al., 2006), 
which facilitates comparison. The design and procedure of the study also follows the 
procedure used by the CORC. We found few other studies reporting findings regarding 
predictors of change in CAMHS outpatient settings. We assessed the impact of multiple 
potential predictors, both demographic and clinical.  
 
Future directions for clinical practice and research in clinical settings 
Based on the findings from this naturalistic observational study and based on my 
experience with doing research in a clinical setting, three questions concerning future 
directions warrants some attention. Firstly, due to several methodological limitations affecting 
 63 
the interpretations of the results in our study, as well as in some other naturalistic 
observational studies, how can clinical studies in naturalistic settings improve the quality of 
the data? Secondly, our study along with other studies about change during CAMHS 
treatment gives reason for concern regarding the effectiveness of such services: What can be 
done to improve outcomes in CAMHS? Finally, considering the fact that so few prognostic 
factors for anxiety and depression treatment outcomes are known: How can the research on 
predictors and moderators of treatment outcome be improved? 
Several issues regarding effort to improve data quality in naturalistic observation 
studies are described in the literature. Which strategies may be used that will enhance the rate 
of return from children, caregivers, and clinicians? For the clinicians part, lack of available 
resources for the collection of clinic data is one important barrier, also noted as relevant 
within services that are members of the CORC (Hall et al., 2013). Many factors, such as 
workload, few resources, etc may partly explain these completion rates. In order to improve 
clinician completion rates, the incentives and the clinical usefulness for completing the 
outcome measurement are important (L Bickman, 2008). Collecting routine outcome 
measurement also requires the commitment and leadership of the service management, and 
also a commitment from clinical and administrative staff. The collection of outcome data 
must be a prioritized and valued task within a busy work schedule.  
Due to the comparatively lower completion rate by service users, their perspective of 
change is under-reported (Hall et al., 2013), which was also the case in the studies of this 
dissertation. Thus, it is important to find ways to improve response rates of service users. 
Whether data is collected during treatment or post-treatment only may impact response rate 
since the dropout rates among adolescents tend to be high. Therefore it can be wise to collect 
several data waves with shorter time intervals to ensure follow-up data from a larger 
proportion of individuals. With technological developments, the option of inputting data 
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online electronically, may contribute to increased completion rates by both clinicians and 
service users. Instantaneous feedback on the ratings and visual presentations of change data 
that can be used by the patient, caregivers and therapist together in the session, may make 
such data a more integral part of the service provided.  
What can be done to improve outcomes in CAMHS? This is of course a complex 
issue, and I will only comment on some issues that can be promising venues for quality 
improvement. Firstly, success in improving the quality of a system of care was described in 
Daleiden et al (2006). The results showed beneficial effects of TAU for child symptoms and 
functioning, and child outcomes got better during the period of a quality improvement reform 
(from 1996 to 2005) in child mental health services. In addition, the average length of service 
was reduced by 40 to 60 %. Admission and discharge characteristics of the child population 
was relatively stable during the same time period 
Secondly, routine measurement along with frequent feedback from service users has 
been shown to improve outcomes of CAMHS (L. Bickman, Kelley, Breda, de Andrade, & 
Riemer, 2011; Gondek, Edbrooke-Childs, Fink, Deighton, & Wolpert, 2016; M. J. Lambert & 
Shimokawa, 2011). Another promising venue for quality improvement can be the integration 
of outcome data into everyday clinical practice and decision-making (Edbrooke-Childs et al., 
2015). Bickman et al. (2008) argued that improvement of mental health services requires that 
measurements are administered frequently, which are relevant for the ongoing treatment and 
also provide feedback to the users of the information. In a pre-follow-up design clinicians 
may never see the follow-up data and do not get the chance to adjust their practice according 
to the data or use the data in collaboration with clients (M. Wolpert, 2014). It is important that 
clinicians receive feedback rapidly and supervision in interpreting the data and in 
contextualizing outcomes with other data.  
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Bridging the gap between research and clinical practice have been a goal within child 
mental health for decades (Weisz et al., 1995). Efforts to improve outcomes by disseminating 
evidence-based treatments to CAMHS continue to be important goals within the field. 
Evidence-based treatments protocols have tended to standardize instead of individualize 
treatment and assessment. There is an ongoing shift within mental health care from a focus on 
evidence-based treatments towards personalized interventions (Ng & Weisz, 2016). 
Personalized interventions build on evidence-based methods in translating findings from 
treatment trials into individual treatment plans, tailoring treatment to the needs of the 
individual. In mental health care there is currently insufficient empirical basis for the full 
implementation of such a strategy. Thus, more research in several areas is needed to translate 
knowledge from generic findings on the group level to clinical decision-making at the 
individual level. This applies both to evidence-based treatments and to usual care treatment. 
How can the study of predictors and moderators of treatment be improved? 
Conducting studies with a sufficient number of participants that are representative of the 
target population, having complete data for relevant variables, and including outcome data 
that target relevant domains of change, seem to be important steps. The prevailing finding of 
non-significant associations between potential predictors and treatment change may suggest 
that relevant variables have not yet been assessed properly. As commented on earlier, one 
important step further could be to identify relevant prognostic factors for children and 
adolescent, such as developmentally related variables and to study those variables 
systematically. Examples of developmentally related variables and functioning mentioned 
earlier were emerging social skills, and friendship quality. Factors that are known to impact 
the development and maintenance of disorders may also be relevant prognostic factors for 
treatment change. To enhance our understanding of prognostic factors knowledge is also 
needed concerning negative effects of treatments, about long-term effects of treatments, 
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regarding interaction effects of multimodal treatments (e.g. psychological-, medical and 
psychosocial interventions). Further, we also need knowledge concerning which can be 
expected change trajectories for a specific treatment, as well as knowledge concerning 
predictors, moderators and mediators of different change trajectories (e.g Peris et al., 2015). 
This may enable therapists to set more realistic expectations during the treatment process, and 
to assess progress more accurately through the different phases of the treatment. For the 
future, advances in the field of affective neuroscience may extend our understanding of how 
targeting specific predictors and moderators may alter these results (McMakin et al., 2012). 
For example, when targeting anhedonia (the inability to experience pleasure from activities 
usually found enjoyable) the use of neuroimaging and behavioural assessments can help to 
evaluate if underlying positive affective systems are altered following the intervention, which 
again may result in improving remission rates and recovery among youth  
 
Conclusions 
The current study adds to the limited knowledge of rate of change and predictors of 
rate of change in symptom severity and functional impairment for children and adolescents 
with emotional disorders treated within CAMHS. In conclusion, existing studies of pre-
treatment patient variables as predictors and moderators of anxiety and depression treatment 
outcome provide little consistent knowledge concerning predictors of change during CAMHS 
treatment, or during RCT. Currently, there is little data that clinicians can use to guide 
decisions concerning who might benefit more and who more likely would benefit less to 
treatment (e.g Higa-McMillan et al., 2016), other than high pre-treatment symptom severity 
that is found to be a negative prognostic factor both within anxiety and depression treatment 
studies. Demographic factors such as age and gender do not seem to be a prognostic factor for 
differential change during treatment, neither within naturalistic observation studies within 
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CAMHS nor in RCT studies. Comorbid anxiety and depression also tend to be a predictor of 
less change, but the findings are inconclusive. In our study, children with depression had both 
higher total level of severity at intake and experienced less change during CAMHS treatment. 
This finding may support the notion that depressive disorder has a worse prognosis than 
anxiety disorder when treated, but may also have other plausible explanations. The results 
presented here point to a particular need to improve clinical care for depressed children and 
adolescents. Finally, rates of change during CAMHS treatment show overall improvement, 
but very few individuals experience change that can be defined as clinically significant. For 
the majority of individuals in our study, the degree of change is best classified as uncertain. 
Efforts to improve these services seem warranted.  
The results of the studies of this dissertation point to the importance of evaluating 
change during CAMHS treatment and to study change through different approaches and from 
the perspective of various informants. The focus on prognostic factors for change during 
CAMHS service provision is also an important future venue. In the future, there is a need of 
well-planned and carefully monitored studies in naturalistic settings that keep addressing the 
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